Raras
Buscar doenças, sintomas, genes...
Ataxia hereditária
ORPHA:183518CID-10 · G11DOENÇA RARA

Um exemplo de distúrbio atático causado por uma modificação genômica herdada em um indivíduo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um exemplo de distúrbio atático causado por uma modificação genômica herdada em um indivíduo.

Pesquisas ativas
3 ensaios
13 total registrados no ClinicalTrials.gov
Publicações científicas
515 artigos
Último publicado: 2026 Apr 13

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: G11
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
177 sintomas
🦴
Ossos e articulações
92 sintomas
👁️
Olhos
82 sintomas
💪
Músculos
60 sintomas
😀
Face
58 sintomas
🫃
Digestivo
39 sintomas

+ 580 sintomas em outras categorias

Características mais comuns

Paralisia das cordas vocais
Atividade anormal da cadeia respiratória mitocondrial
Sinostose metópica
Arritmia
Acúmulo de ferro na substância negra
Instabilidade da fixação visual
1284sintomas
Sem dados (1284)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 1284 características clínicas mais associadas, ordenadas por frequência.

Paralisia das cordas vocaisVocal cord paralysis
Atividade anormal da cadeia respiratória mitocondrialAbnormal activity of mitochondrial respiratory chain
Sinostose metópicaMetopic synostosis
ArritmiaArrhythmia
Acúmulo de ferro na substância negraIron accumulation in substantia nigra

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico515PubMed
Últimos 10 anos200publicações
Pico202532 papers
Linha do tempo
2026Hoje · 2026🧪 1999Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

79 genes identificados com associação a esta condição.

RPGRIP1LProtein fantomCandidate gene tested inTolerante
FUNÇÃO

Negatively regulates signaling through the G-protein coupled thromboxane A2 receptor (TBXA2R) (PubMed:19464661). May be involved in mechanisms like programmed cell death, craniofacial development, patterning of the limbs, and formation of the left-right axis (By similarity). Involved in the organization of apical junctions; the function is proposed to implicate a NPHP1-4-8 module. Does not seem to be strictly required for ciliogenesis (PubMed:19464661). Involved in establishment of planar cell p

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell junction, tight junction

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.1 TPM
Fibroblastos
7.3 TPM
Pituitária
5.6 TPM
Ovário
3.0 TPM
Cervix Endocervix
3.0 TPM
OUTRAS DOENÇAS (6)
Meckel syndrome, type 5Joubert syndrome 7COACH syndrome 3COACH syndrome
HGNC:29168UniProt:Q68CZ1
SCYL1N-terminal kinase-like proteinCandidate gene tested inTolerante
FUNÇÃO

Regulates COPI-mediated retrograde protein traffic at the interface between the Golgi apparatus and the endoplasmic reticulum (PubMed:18556652). Involved in the maintenance of the Golgi apparatus morphology (PubMed:26581903) Acts as a transcriptional activator. It binds to three different types of GC-rich DNA binding sites (box-A, -B and -C) in the beta-polymerase promoter region. It also binds to the TERT promoter region

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeEndoplasmic reticulum-Golgi intermediate compartmentGolgi apparatus, cis-Golgi networkCytoplasmNucleus

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 21

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR21 is characterized by cerebellar atrophy and ataxia with onset in early childhood. Patients also manifest recurrent episodes of liver failure, hepatic fibrosis and a peripheral neuropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
109.2 TPM
Ovário
108.0 TPM
Cervix Endocervix
107.9 TPM
Cervix Ectocervix
106.3 TPM
Testículo
106.2 TPM
OUTRAS DOENÇAS (1)
acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome
HGNC:14372UniProt:Q96KG9
WWOXWW domain-containing oxidoreductaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm

LOCALIZAÇÃO

CytoplasmNucleusMitochondrionGolgi apparatusLysosome

VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7
RNU12Candidate gene tested inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
RNA polymerase II transcribes snRNA genes
OUTRAS DOENÇAS (3)
craniosynostosis-anal anomalies-porokeratosis syndromespinocerebellar ataxia, autosomal recessive 33congenital cerebellar ataxia due to RNU12 mutation
HGNC:19380
VLDLRVery low-density lipoprotein receptorCandidate gene tested inTolerante
FUNÇÃO

Multifunctional cell surface receptor that binds VLDL and transports it into cells by endocytosis and therefore plays an important role in energy metabolism. Also binds to a wide range of other molecules including Reelin/RELN or apolipoprotein E/APOE-containing ligands as well as clusterin/CLU (PubMed:24381170, PubMed:30873003). In the off-state of the pathway, forms homooligomers or heterooligomers with LRP8 (PubMed:30873003). Upon binding to ligands, homooligomers are rearranged to higher orde

LOCALIZAÇÃO

Cell membraneMembrane, clathrin-coated pit

VIAS BIOLÓGICAS (3)
VLDL clearanceVLDLR internalisation and degradationReelin signalling pathway
MECANISMO DE DOENÇA

Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 1

An autosomal recessive, congenital, non-progressive cerebellar ataxia associated with disturbed equilibrium, delayed ambulation, intellectual disability, cerebellar hypoplasia and mild cerebral gyral simplification. Additional features include short stature, strabismus, pes planus and, rarely, seizures.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
81.6 TPM
Artéria tibial
18.7 TPM
Coração - Átrio
18.7 TPM
Coração - Ventrículo esquerdo
16.5 TPM
Fallopian Tube
15.2 TPM
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:12698UniProt:P98155
PDYNProenkephalin-BDisease-causing germline mutation(s) inModerado
FUNÇÃO

Leu-enkephalins compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions, including pain perception and responses to stress (By similarity) Dynorphin peptides differentially regulate the kappa opioid receptor. Dynorphin A(1-13) has a typical opioid activity, it is 700 times more potent than Leu-enkephalin (By similarity) Leumorphin has a typical opioid activity and may have anti-apoptotic effect

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
G alpha (i) signalling eventsPeptide ligand-binding receptors
MECANISMO DE DOENÇA

Spinocerebellar ataxia 23

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA23 is an adult-onset autosomal dominant form characterized by slowly progressive gait and limb ataxia, with variable additional features, including peripheral neuropathy and dysarthria.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
108.5 TPM
Brain Caudate basal ganglia
26.5 TPM
Brain Putamen basal ganglia
11.1 TPM
Testículo
8.9 TPM
Hipotálamo
6.7 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 23
HGNC:8820UniProt:P01213
ATXN2Ataxin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in EGFR trafficking, acting as negative regulator of endocytic EGFR internalization at the plasma membrane

LOCALIZAÇÃO

Cytoplasm

MECANISMO DE DOENÇA

Spinocerebellar ataxia 2

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA2 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA2 is characterized by hyporeflexia, myoclonus and action tremor and dopamine-responsive parkinsonism. In some patients, SCA2 presents as pure familial parkinsonism without cerebellar signs.

OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 2amyotrophic lateral sclerosislate-onset Parkinson disease
HGNC:10555UniProt:Q99700
PNPLA6Patatin-like phospholipase domain-containing protein 6Candidate gene tested inTolerante
FUNÇÃO

Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Catalyzes the hydrolysis of several naturally occurring membrane-associated lipids (PubMed:11927584). Hydrolyzes lysophospholipids and monoacylglycerols, preferring the 1-acyl to the 2-acyl isomer. Does not catalyze hydrolysis of di- or triacylglycerols or fatty acid amides (PubMed:11927584)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Glycerophospholipid catabolism
MECANISMO DE DOENÇA

Spastic paraplegia 39, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
75.4 TPM
Pulmão
74.4 TPM
Baço
65.5 TPM
Pituitária
51.6 TPM
Sangue
49.8 TPM
OUTRAS DOENÇAS (5)
hereditary spastic paraplegia 39trichomegaly-retina pigmentary degeneration-dwarfism syndromeataxia-hypogonadism-choroidal dystrophy syndromeLaurence-Moon syndrome
HGNC:16268UniProt:Q8IY17
TUBB2BTubulin beta-2B chainCandidate gene tested inAltamente restrito
FUNÇÃO

Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers (PubMed:23001566, PubMed:26732629, PubMed:28013290). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. Plays a critical role in proper axon guidance in both central and periph

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Cortical dysplasia, complex, with other brain malformations 7

A malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
377.8 TPM
Brain Nucleus accumbens basal ganglia
248.1 TPM
Substância negra
229.1 TPM
Hipotálamo
205.3 TPM
Brain Caudate basal ganglia
203.2 TPM
OUTRAS DOENÇAS (4)
complex cortical dysplasia with other brain malformations 7tubulinopathy-associated dysgyriacerebellar ataxia, intellectual disability, and dysequilibriumcongenital fibrosis of extraocular muscles
HGNC:30829UniProt:Q9BVA1
PEX10Peroxisome biogenesis factor 10Candidate gene tested inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase component of a retrotranslocation channel required for peroxisome organization by mediating export of the PEX5 receptor from peroxisomes to the cytosol, thereby promoting PEX5 recycling (PubMed:24662292). The retrotranslocation channel is composed of PEX2, PEX10 and PEX12; each subunit contributing transmembrane segments that coassemble into an open channel that specifically allows the passage of PEX5 through the peroxisomal membrane (By similarity). PEX10 also regula

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (2)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteins
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 7

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
33.5 TPM
Glândula adrenal
23.3 TPM
Brain Spinal cord cervical c-1
22.1 TPM
Nervo tibial
20.8 TPM
Fibroblastos
20.1 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 6Bperoxisome biogenesis disorder 6A (Zellweger)autosomal recessive ataxia due to PEX10 deficiencyZellweger spectrum disorders
HGNC:8851UniProt:O60683
TMEM231Transmembrane protein 231Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transmembrane component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for ciliogenesis and sonic hedgehog/SHH signaling (By similarity)

LOCALIZAÇÃO

Cell projection, cilium membrane

MECANISMO DE DOENÇA

Joubert syndrome 20

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
14.2 TPM
Pituitária
13.8 TPM
Fallopian Tube
12.9 TPM
Cervix Endocervix
12.0 TPM
Útero
11.8 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 20Meckel syndrome, type 11Meckel syndromeJoubert syndrome with oculorenal defect
HGNC:37234UniProt:Q9H6L2
GRM1Metabotropic glutamate receptor 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system. May participate in the central action of glutamate in the CNS, such as long-term potentiation in the hippocampus and long-term depression in the cerebellum (PubMed:24603153, PubMed:28886343, PubMed:7476890).

LOCALIZAÇÃO

Cell membranePostsynaptic cell membraneCell projection, dendrite

VIAS BIOLÓGICAS (3)
G alpha (q) signalling eventsClass C/3 (Metabotropic glutamate/pheromone receptors)Neurexins and neuroligins
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 13

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR13 is characterized by delayed psychomotor development beginning in infancy. Affected individuals show mild to profound intellectual disability with poor or absent speech as well as gait and stance ataxia and hyperreflexia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
38.4 TPM
Cerebelo
30.6 TPM
Brain Frontal Cortex BA9
5.7 TPM
Córtex cerebral
3.6 TPM
Brain Anterior cingulate cortex BA24
3.6 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia 44autosomal recessive spinocerebellar ataxia 13chondromyxoid fibroma
HGNC:4593UniProt:Q13255
THG1LProbable tRNA(His) guanylyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Adds a GMP to the 5'-end of tRNA(His) after transcription and RNase P cleavage. This step is essential for proper recognition of the tRNA and for the fidelity of protein synthesis (Probable). Also functions as a guanyl-nucleotide exchange factor/GEF for the MFN1 and MFN2 mitofusins thereby regulating mitochondrial fusion (PubMed:25008184, PubMed:27307223). By regulating both mitochondrial dynamics and bioenergetic function, it contributes to cell survival following oxidative stress (PubMed:25008

LOCALIZAÇÃO

CytoplasmMitochondrion outer membrane

VIAS BIOLÓGICAS (1)
tRNA modification in the nucleus and cytosol
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 28

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR28 patients manifest mild motor developmental delay, gait ataxia, and dysarthria. Some patients show mildly impaired intellectual development. Disease onset is in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
20.2 TPM
Fibroblastos
17.3 TPM
Bladder
15.8 TPM
Útero
15.3 TPM
Cervix Ectocervix
15.1 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 28
HGNC:HGNC:26053UniProt:Q9NWX6
FGF14Fibroblast growth factor 14Candidate gene tested inAltamente restrito
FUNÇÃO

Probably involved in nervous system development and function

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Phase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 27A

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA27A is an autosomal dominant, slowly progressive form characterized by gait disturbances, ataxia with tremor, dysarthria, orofacial dyskinesia, gaze-evoked nystagmus, and learning disabilities. There is significant variability, and patients show various combinations of neurologic features.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
20.7 TPM
Cerebelo
16.5 TPM
Brain Frontal Cortex BA9
7.5 TPM
Brain Nucleus accumbens basal ganglia
5.5 TPM
Córtex cerebral
4.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
spinocerebellar ataxia 27Aspinocerebellar ataxia 27B, late-onsetspinocerebellar ataxia type 27
HGNC:3671UniProt:Q92915
ATN1Atrophin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats

LOCALIZAÇÃO

NucleusCytoplasm, perinuclear regionCell junction

VIAS BIOLÓGICAS (1)
Regulation of PTEN gene transcription
MECANISMO DE DOENÇA

Dentatorubral-pallidoluysian atrophy

Autosomal dominant neurodegenerative disorder characterized by a loss of neurons in the dentate nucleus, rubrum, glogus pallidus and Luys'body. Clinical features are myoclonus epilepsy, dementia, and cerebellar ataxia. Onset of the disease occurs usually in the second decade of life and death in the fourth.

OUTRAS DOENÇAS (2)
dentatorubral-pallidoluysian atrophycongenital hypotonia, epilepsy, developmental delay, and digital anomalies
HGNC:3033UniProt:P54259
KCND3A-type voltage-gated potassium channel KCND3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming (alpha) subunit of voltage-gated A-type potassium channels that mediates transmembrane potassium transport in excitable membranes, in brain and heart (PubMed:10200233, PubMed:17187064, PubMed:21349352, PubMed:22457051, PubMed:23280837, PubMed:23280838, PubMed:34997220, PubMed:9843794). In cardiomyocytes, may generate the transient outward potassium current I(To) (By similarity). In neurons, may conduct the transient subthreshold somatodendritic A-type potassium current (ISA) (By sim

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemmaCell projection, dendrite

VIAS BIOLÓGICAS (2)
Phase 1 - inactivation of fast Na+ channelsVoltage gated Potassium channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia 19

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA19 is a relatively mild, cerebellar ataxic syndrome with cognitive impairment, pyramidal tract involvement, tremor and peripheral neuropathy, and mild atrophy of the cerebellar hemispheres and vermis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
62.6 TPM
Cerebelo
56.0 TPM
Brain Frontal Cortex BA9
23.7 TPM
Córtex cerebral
19.4 TPM
Esôfago - Muscular
16.0 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 19/22Brugada syndrome 9Brugada syndrome
HGNC:6239UniProt:Q9UK17
ANO10Anoctamin-10Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Does not exhibit calcium-activated chloride channel (CaCC) activity. Can inhibit the activity of ANO1

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Induction of Cell-Cell FusionStimuli-sensing channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 10

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR10 is characterized by onset in the teenage or young adult years of gait and limb ataxia, dysarthria, and nystagmus associated with marked cerebellar atrophy on brain imaging.

OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 10
HGNC:25519UniProt:Q9NW15
EEF2Elongation factor 2Candidate gene tested inAltamente restrito
FUNÇÃO

Catalyzes the GTP-dependent ribosomal translocation step during translation elongation (PubMed:26593721). During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively (PubMed:26593721). Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome (PubMed:26593721)

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 26

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
2998.1 TPM
Fibroblastos
2856.0 TPM
Linfócitos
2101.6 TPM
Cervix Endocervix
1850.1 TPM
Útero
1835.9 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 26
HGNC:3214UniProt:P13639
FMR1Fragile X messenger ribonucleoprotein 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Multifunctional polyribosome-associated RNA-binding protein that plays a central role in neuronal development and synaptic plasticity through the regulation of alternative mRNA splicing, mRNA stability, mRNA dendritic transport and postsynaptic local protein synthesis of target mRNAs (PubMed:12417522, PubMed:16631377, PubMed:18653529, PubMed:19166269, PubMed:23235829, PubMed:25464849). Acts as an mRNA regulator by mediating formation of some phase-separated membraneless compartment: undergoes li

LOCALIZAÇÃO

Cytoplasm, Cytoplasmic ribonucleoprotein granuleCytoplasm, Stress granuleCytoplasmPerikaryonCytoplasm, perinuclear regionCell projection, neuron projectionCell projection, axonCell projection, dendriteCell projection, dendritic spineSynapse, synaptosomeCell projection, growth coneCell projection, filopodium tipSynapsePostsynaptic cell membranePresynaptic cell membraneNucleusNucleus, nucleolusChromosome, centromereChromosomeCell membraneNucleus, Cajal body

VIAS BIOLÓGICAS (5)
FCGR3A-mediated phagocytosisRHO GTPases Activate WASPs and WAVEsRegulation of actin dynamics for phagocytic cup formationVEGFA-VEGFR2 PathwayRAC1 GTPase cycle
MECANISMO DE DOENÇA

Fragile X syndrome

An X-linked dominant disease characterized by moderate to severe intellectual disability, macroorchidism (enlargement of the testicles), large ears, prominent jaw, and high-pitched, jocular speech. The defect in most patients results from an amplification of a CGG repeat region in the FMR1 gene and abnormal methylation.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
39.4 TPM
Ovário
32.4 TPM
Tireoide
31.7 TPM
Nervo tibial
30.4 TPM
Cerebelo
29.7 TPM
OUTRAS DOENÇAS (4)
premature ovarian failure 1fragile X syndromefragile X-associated tremor/ataxia syndromeXq27.3q28 duplication syndrome
HGNC:3775UniProt:Q06787
POLR3ADNA-directed RNA polymerase III subunit RPC1Candidate gene tested inTolerante
FUNÇÃO

Catalytic core component of RNA polymerase III (Pol III), a DNA-dependent RNA polymerase which synthesizes small non-coding RNAs using the four ribonucleoside triphosphates as substrates. Synthesizes 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci (PubMed:19609254, PubMed:19631370, PubMed:20413673, PubMed:33335104, PubMed:33558764, PubMed:33558766, PubMed:34675218, PubMed:35637192, PubMed:9331371). Pol III-mediated transcription cycle proceeds through transcription init

LOCALIZAÇÃO

NucleusCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Cytosolic sensors of pathogen-associated DNA
MECANISMO DE DOENÇA

Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism

An autosomal recessive neurodegenerative disorder characterized by childhood onset of progressive motor decline manifest as spasticity, ataxia, tremor, and cerebellar signs, as well as mild cognitive regression. Other features may include hypodontia or oligodontia and hypogonadotropic hypogonadism. There is considerable inter- and intrafamilial variability.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
19.6 TPM
Cerebelo
18.6 TPM
Pituitária
15.8 TPM
Fibroblastos
14.5 TPM
Linfócitos
12.7 TPM
OUTRAS DOENÇAS (7)
leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadismWiedemann-Rautenstrauch syndrometremor-ataxia-central hypomyelination syndromeodontoleukodystrophy
HGNC:30074UniProt:O14802
TWNKTwinkle mtDNA helicaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Mitochondrial helicase involved in mtDNA replication and repair (PubMed:12975372, PubMed:15167897, PubMed:17324440, PubMed:18039713, PubMed:18971204, PubMed:25824949, PubMed:26887820, PubMed:27226550). Might have a role in mtDNA repair (PubMed:27226550). Has DNA strand separation activity needed to form a processive replication fork for leading strand synthesis which is catalyzed by the formation of a replisome complex with POLG and mtSDB (PubMed:12975372, PubMed:15167897, PubMed:18039713, PubMe

LOCALIZAÇÃO

Mitochondrion matrix, mitochondrion nucleoidMitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Strand-asynchronous mitochondrial DNA replicationMitochondrial protein degradationTranscriptional activation of mitochondrial biogenesis
MECANISMO DE DOENÇA

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3

A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
21.9 TPM
Testículo
20.3 TPM
Fibroblastos
14.6 TPM
Ovário
10.6 TPM
Útero
10.3 TPM
OUTRAS DOENÇAS (8)
mitochondrial DNA depletion syndrome 7 (hepatocerebral type)Perrault syndrome 5progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3autosomal dominant progressive external ophthalmoplegia
HGNC:1160UniProt:Q96RR1
CC2D2ACoiled-coil and C2 domain-containing protein 2ACandidate gene tested inTolerante
FUNÇÃO

Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for ciliogenesis and sonic hedgehog/SHH signaling (By similarity)

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 6

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

OUTRAS DOENÇAS (8)
retinitis pigmentosa 93COACH syndrome 2Joubert syndrome 9Meckel syndrome, type 6
HGNC:29253UniProt:Q9P2K1
KCNC3Voltage-gated potassium channel KCNC3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Voltage-gated potassium channel that plays an important role in the rapid repolarization of fast-firing brain neurons. The channel opens in response to the voltage difference across the membrane, forming a potassium-selective channel through which potassium ions pass in accordance with their electrochemical gradient. The channel displays rapid activation and inactivation kinetics (PubMed:10712820, PubMed:16501573, PubMed:19953606, PubMed:21479265, PubMed:22289912, PubMed:23734863, PubMed:2575679

LOCALIZAÇÃO

Cell membranePresynaptic cell membranePerikaryonCell projection, axonCell projection, dendriteCell projection, dendritic spine membraneCytoplasm, cell cortexCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia 13

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA13 is an autosomal dominant cerebellar ataxia (ADCA) characterized by slow progression and variable age at onset, ranging from childhood to late adulthood. Intellectual disability can be present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
78.2 TPM
Tireoide
63.5 TPM
Cérebro - Hemisfério cerebelar
61.8 TPM
Pituitária
24.0 TPM
Brain Frontal Cortex BA9
22.1 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 13
HGNC:6235UniProt:Q14003
PNKPBifunctional polynucleotide phosphatase/kinaseCandidate gene tested inTolerante
FUNÇÃO

Plays a key role in the repair of DNA damage, functioning as part of both the non-homologous end-joining (NHEJ) and base excision repair (BER) pathways (PubMed:10446192, PubMed:10446193, PubMed:15385968, PubMed:20852255, PubMed:28453785). Through its two catalytic activities, PNK ensures that DNA termini are compatible with extension and ligation by either removing 3'-phosphates from, or by phosphorylating 5'-hydroxyl groups on, the ribose sugar of the DNA backbone (PubMed:10446192, PubMed:10446

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (1)
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
MECANISMO DE DOENÇA

Microcephaly, seizures, and developmental delay

An autosomal recessive neurodevelopmental disorder characterized by infantile-onset seizures, microcephaly, severe intellectual disability and delayed motor milestones with absent speech or only achieving a few words. Most patients also have behavioral problems with hyperactivity. Microcephaly is progressive and without neuronal migration or structural abnormalities, consistent with primary microcephaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
66.8 TPM
Tireoide
63.9 TPM
Baço
59.2 TPM
Glândula adrenal
55.9 TPM
Cervix Endocervix
51.8 TPM
OUTRAS DOENÇAS (4)
microcephaly, seizures, and developmental delayataxia - oculomotor apraxia type 4Charcot-Marie-Tooth disease type 2B2early-infantile DEE
HGNC:9154UniProt:Q96T60
PITRM1Presequence protease, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Metalloendopeptidase of the mitochondrial matrix that functions in peptide cleavage and degradation rather than in protein processing (PubMed:10360838, PubMed:16849325, PubMed:19196155, PubMed:24931469). Has an ATP-independent activity (PubMed:16849325). Specifically cleaves peptides in the range of 5 to 65 residues (PubMed:19196155). Shows a preference for cleavage after small polar residues and before basic residues, but without any positional preference (PubMed:10360838, PubMed:19196155, PubM

LOCALIZAÇÃO

MitochondrionMitochondrion matrix

VIAS BIOLÓGICAS (1)
Mitochondrial protein import
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 30

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR30 is a progressive disease characterized by childhood-onset global developmental delay with variably impaired intellectual development, motor dysfunction, and cerebellar ataxia. Affected individuals may also have psychiatric abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
58.3 TPM
Aorta
58.3 TPM
Artéria tibial
56.3 TPM
Testículo
52.8 TPM
Útero
50.9 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 30
HGNC:HGNC:17663UniProt:Q5JRX3
CACNA1GVoltage-dependent T-type calcium channel subunit alpha-1GDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1G gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group and are strongly blocked by mibefradil. A particularity of this type of c

LOCALIZAÇÃO

Cell membraneCytoplasm

VIAS BIOLÓGICAS (2)
NCAM1 interactionsSmooth Muscle Contraction
MECANISMO DE DOENÇA

Spinocerebellar ataxia 42

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA42 is a slowly progressive, autosomal dominant form with variable severity.

OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 42spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
HGNC:1394UniProt:O43497
POU4F1POU domain, class 4, transcription factor 1Candidate gene tested inAltamente restrito
FUNÇÃO

Multifunctional transcription factor with different regions mediating its different effects. Acts by binding (via its C-terminal domain) to sequences related to the consensus octamer motif 5'-ATGCAAAT-3' in the regulatory regions of its target genes. Regulates the expression of specific genes involved in differentiation and survival within a subset of neuronal lineages. It has been shown that activation of some of these genes requires its N-terminal domain, maybe through a neuronal-specific cofa

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Regulation of TP53 Activity through Association with Co-factors
MECANISMO DE DOENÇA

Ataxia, intention tremor, and hypotonia syndrome, childhood-onset

An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, mildly impaired intellectual development with speech delay or learning disabilities, delayed walking due to ataxia, intention tremor, and hypotonia apparent from early childhood. Brain imaging shows cerebellar atrophy in some patients.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.1 TPM
Linfócitos
0.4 TPM
Brain Spinal cord cervical c-1
0.4 TPM
Skin Sun Exposed Lower leg
0.1 TPM
Skin Not Sun Exposed Suprapubic
0.1 TPM
OUTRAS DOENÇAS (2)
ataxia, intention tremor, and hypotonia syndrome, childhood-onsetcerebellar dysfunction with variable cognitive and behavioral abnormalities
HGNC:9218UniProt:Q01851
TMEM237Transmembrane protein 237Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the transition zone in primary cilia. Required for ciliogenesis

LOCALIZAÇÃO

MembraneCell projection, cilium

MECANISMO DE DOENÇA

Joubert syndrome 14

An autosomal recessive disorder characterized by severe intellectual disability, hypotonia, breathing abnormalities in infancy, and dysmorphic facial features. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include renal disease, abnormal eye movements, and postaxial polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
30.8 TPM
Skin Not Sun Exposed Suprapubic
24.6 TPM
Skin Sun Exposed Lower leg
22.7 TPM
Artéria tibial
20.4 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 14Meckel syndromeJoubert syndrome with oculorenal defectJoubert syndrome
HGNC:14432UniProt:Q96Q45
MARS2Methionine--tRNA ligase, mitochondrialCandidate gene tested inTolerante
LOCALIZAÇÃO

Mitochondrion matrix

VIAS BIOLÓGICAS (1)
Mitochondrial tRNA aminoacylation
MECANISMO DE DOENÇA

Spastic ataxia 3, autosomal recessive

A neurologic disorder characterized by cerebellar ataxia, ataxic gait, spasticity, and hyperreflexia. Other variable features include dysarthria, dysmetria, mild cognitive impairment, urinary urgency and dystonic positioning.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
25.8 TPM
Esôfago - Mucosa
7.7 TPM
Baço
7.5 TPM
Fibroblastos
7.2 TPM
Glândula adrenal
7.2 TPM
OUTRAS DOENÇAS (2)
spastic ataxia 3combined oxidative phosphorylation defect type 25
HGNC:25133UniProt:Q96GW9
NKX6-2Homeobox protein Nkx-6.2Candidate gene tested inTolerante
FUNÇÃO

Transcription factor with repressor activity involved in the regulation of axon-glial interactions at myelin paranodes in oligodendrocytes. Binds to the consensus DNA sequence 5'-(A/T)TTAATGA-3'. In oligodendrocytes, binds to MBP and PLP1 promoter regions

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Regulation of gene expression in early pancreatic precursor cellsRegulation of gene expression in beta cellsDevelopmental Lineage of Multipotent Pancreatic Progenitor CellsDevelopmental Lineage of Pancreatic Ductal CellsDevelopmental Lineage of Pancreatic Acinar Cells
MECANISMO DE DOENÇA

Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy

An autosomal recessive neurodegenerative disorder characterized by early-onset hypotonia which progresses to a pyramidal syndrome with ataxia, spasticity, hyperreflexia, weakness and loss of ambulation. Brain imaging shows cerebellar atrophy and hypomyelinating leukodystrophy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
147.1 TPM
Substância negra
53.3 TPM
Hipocampo
43.3 TPM
Brain Putamen basal ganglia
30.9 TPM
Hipotálamo
26.2 TPM
OUTRAS DOENÇAS (1)
spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy
HGNC:19321UniProt:Q9C056
FXNFrataxin, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions as an activator of persulfide transfer to the scaffoding protein ISCU as component of the core iron-sulfur cluster (ISC) assembly complex and participates to the [2Fe-2S] cluster assembly (PubMed:12785837, PubMed:24971490). Accelerates sulfur transfer from NFS1 persulfide intermediate to ISCU and to small thiols such as L-cysteine and glutathione leading to persulfuration of these thiols and ultimately sulfide release (PubMed:24971490). Binds ferrous ion and is released from FXN upon t

LOCALIZAÇÃO

MitochondrionCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Mitochondrial protein import
MECANISMO DE DOENÇA

Friedreich ataxia

Autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
12.5 TPM
Linfócitos
11.2 TPM
Glândula adrenal
10.8 TPM
Fibroblastos
10.6 TPM
Útero
9.3 TPM
OUTRAS DOENÇAS (2)
Friedreich ataxia 1Friedreich ataxia
HGNC:3951UniProt:Q16595
GRID2Glutamate receptor ionotropic, delta-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Member of the ionotropic glutamate receptor family, which plays a crucial role in synaptic organization and signal transduction in the central nervous system. Although it shares structural features with ionotropic glutamate receptors, does not bind glutamate as a primary ligand (PubMed:34936451). Promotes synaptogenesis and mediates the D-Serine-dependent long term depression signals and AMPA receptor endocytosis of cerebellar parallel fiber-Purkinje cell (PF-PC) synapses through the NRX1B-CBLN1

LOCALIZAÇÃO

Postsynaptic cell membrane

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 18

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR18 features include progressive cerebellar atrophy, delayed psychomotor development, severely impaired gait, ocular movement abnormalities, and intellectual disability.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
10.4 TPM
Cérebro - Hemisfério cerebelar
7.5 TPM
Testículo
6.2 TPM
Brain Nucleus accumbens basal ganglia
1.8 TPM
Hipotálamo
1.6 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 18
HGNC:4576UniProt:O43424
PPP2R2BSerine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoformDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localization of the catalytic enzyme to a particular subcellular compartment. Within the PP2A holoenzyme complex, isoform 2 is required to promote proapoptotic activity (By similarity). Isoform 2 regulates neuronal survival through the mitochondrial fission and fusion balance (By similarity)

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonMembraneMitochondrionMitochondrion outer membrane

MECANISMO DE DOENÇA

Spinocerebellar ataxia 12

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA12 is an autosomal dominant cerebellar ataxia (ADCA).

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
29.9 TPM
Brain Nucleus accumbens basal ganglia
24.8 TPM
Córtex cerebral
24.7 TPM
Brain Caudate basal ganglia
22.5 TPM
Brain Anterior cingulate cortex BA24
20.2 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 12
HGNC:9305UniProt:Q00005
SAMD9LSterile alpha motif domain-containing protein 9-likeCandidate gene tested inTolerante
FUNÇÃO

May be involved in endosome fusion. Mediates down-regulation of growth factor signaling via internalization of growth factor receptors

LOCALIZAÇÃO

Early endosomeMitochondrion

MECANISMO DE DOENÇA

Ataxia-pancytopenia syndrome

An autosomal dominant disorder characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to bone marrow failure and myeloid leukemia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
55.2 TPM
Baço
34.1 TPM
Pulmão
22.9 TPM
Nervo tibial
17.2 TPM
Cervix Endocervix
14.3 TPM
OUTRAS DOENÇAS (4)
monosomy 7 myelodysplasia and leukemia syndrome 1ataxia-pancytopenia syndromespinocerebellar ataxia 49SAMD9L-associated autoinflammatory syndrome
HGNC:1349UniProt:Q8IVG5
TMEM216Transmembrane protein 216Candidate gene tested inTolerante
FUNÇÃO

Essential for primary ciliogenesis and embryonic development, facilitating the activation of Hedgehog (Hh) signaling pathway. Disrupts the interaction of GLI2 and GLI3 with the negative regulator SUFU. Inhibiting SUFU's interaction with GLI2 promotes the entry of GLI2 into the nucleus, allowing it to activate Hh target gene expression. Disrupting SUFU's interaction with GLI3 prevents its conversion into the repressor form, leading to increased nuclear GLI3 and enhanced Hh signaling. Required for

LOCALIZAÇÃO

MembraneCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 2

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
31.3 TPM
Pituitária
27.0 TPM
Cervix Endocervix
25.9 TPM
Cervix Ectocervix
24.7 TPM
Testículo
23.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 98Meckel syndrome, type 2Joubert syndrome 2Meckel syndrome
HGNC:25018UniProt:Q9P0N5
SLC9A1Sodium/hydrogen exchanger 1Candidate gene tested inAltamente restrito
FUNÇÃO

Electroneutral Na(+) /H(+) antiporter that extrudes Na(+) in exchange for external protons driven by the inward sodium ion chemical gradient, protecting cells from acidification that occurs from metabolism (PubMed:11350981, PubMed:11532004, PubMed:14680478, PubMed:15035633, PubMed:15677483, PubMed:17073455, PubMed:17493937, PubMed:22020933, PubMed:27650500, PubMed:32130622, PubMed:7110335, PubMed:7603840). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry (By similar

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (2)
Hyaluronan degradationSodium/Proton exchangers
MECANISMO DE DOENÇA

Lichtenstein-Knorr syndrome

An autosomal recessive neurologic disorder characterized by progressive cerebellar ataxia and severe progressive sensorineural hearing loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
33.1 TPM
Glândula salivar
30.3 TPM
Cólon transverso
29.6 TPM
Pulmão
29.2 TPM
Cervix Ectocervix
28.0 TPM
OUTRAS DOENÇAS (1)
Lichtenstein-Knorr syndrome
HGNC:11071UniProt:P19634
PMPCAMitochondrial-processing peptidase subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Substrate recognition and binding subunit of the essential mitochondrial processing protease (MPP), which cleaves the mitochondrial sequence off newly imported precursors proteins

LOCALIZAÇÃO

Mitochondrion matrixMitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Mitochondrial protein importProcessing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 2

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR2 is characterized by onset of impaired motor development and ataxic gait in early childhood. Additional features often include loss of fine motor skills, dysarthria, nystagmus, cerebellar signs, and delayed cognitive development with intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
65.9 TPM
Testículo
61.0 TPM
Fibroblastos
58.4 TPM
Glândula adrenal
52.2 TPM
Nervo tibial
50.4 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 2
HGNC:18667UniProt:Q10713
GDAP2Ganglioside-induced differentiation-associated protein 2Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 27

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR27 is a progressive disease characterized by gait difficulties, eye movement abnormalities, dysarthria, and difficulty writing. Some patients may lose independent ambulation. Additional features include spasticity of the lower limbs and cognitive impairment.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
5.4 TPM
Cervix Endocervix
4.7 TPM
Pulmão
4.5 TPM
Tireoide
4.4 TPM
Cervix Ectocervix
4.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 27
HGNC:HGNC:18010UniProt:Q9NXN4
CEP290Centrosomal protein of 290 kDaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in early and late steps in cilia formation. Its association with CCP110 is required for inhibition of primary cilia formation by CCP110 (PubMed:18694559). May play a role in early ciliogenesis in the disappearance of centriolar satellites and in the transition of primary ciliar vesicles (PCVs) to capped ciliary vesicles (CCVs). Required for the centrosomal recruitment of RAB8A and for the targeting of centriole satellite proteins to centrosomes such as of PCM1 (PubMed:24421332). Require

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteNucleusCell projection, ciliumCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasmic vesicle

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 5

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.

OUTRAS DOENÇAS (10)
Senior-Loken syndrome 6Leber congenital amaurosis 10Joubert syndrome 5Meckel syndrome, type 4
HGNC:29021UniProt:O15078
ELOVL4Very long chain fatty acid elongase 4Disease-causing germline mutation(s) inModerado
FUNÇÃO

Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that catalyzes the synthesis of very long chain saturated (VLC-SFA) and polyunsaturated (PUFA) fatty acids that are involved in multiple biological processes as precursors of membrane lipids and

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of very long-chain fatty acyl-CoAs
MECANISMO DE DOENÇA

Stargardt disease 3

A form of Stargardt disease, a common hereditary macular degeneration characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD3 is an autosomal dominant form with onset most commonly in the second decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
68.2 TPM
Skin Not Sun Exposed Suprapubic
64.1 TPM
Cérebro - Hemisfério cerebelar
43.9 TPM
Cerebelo
27.9 TPM
Brain Frontal Cortex BA9
23.3 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 34Stargardt disease 3congenital ichthyosis-intellectual disability-spastic quadriplegia syndromeStargardt disease
HGNC:14415UniProt:Q9GZR5
TDP2Tyrosyl-DNA phosphodiesterase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA repair enzyme that can remove a variety of covalent adducts from DNA through hydrolysis of a 5'-phosphodiester bond, giving rise to DNA with a free 5' phosphate. Catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase 2 (TOP2) active site tyrosine residue. The 5'-tyrosyl DNA phosphodiesterase activity can enable the repair of TOP2-induced DNA double-strand breaks/DSBs without the need for nuclease activity, creating a 'clean' DSB with 5'-phosphate termini that are re

LOCALIZAÇÃO

NucleusNucleus, PML bodyNucleus, nucleolusCytoplasm

VIAS BIOLÓGICAS (1)
Nonhomologous End-Joining (NHEJ)
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 23

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR23 patients manifest epilepsy, intellectual disability, and gait ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Intestino delgado
57.6 TPM
Cérebro - Hemisfério cerebelar
47.5 TPM
Cólon transverso
46.9 TPM
Próstata
44.4 TPM
Linfócitos
41.8 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 23
HGNC:17768UniProt:O95551
PEX6Peroxisomal ATPase PEX6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the PEX1-PEX6 AAA ATPase complex, a protein dislocase complex that mediates the ATP-dependent extraction of the PEX5 receptor from peroxisomal membranes, an essential step for PEX5 recycling (PubMed:16314507, PubMed:16854980, PubMed:21362118, PubMed:29884772). Specifically recognizes PEX5 monoubiquitinated at 'Cys-11', and pulls it out of the peroxisome lumen through the PEX2-PEX10-PEX12 retrotranslocation channel (PubMed:29884772). Extraction by the PEX1-PEX6 AAA ATPase complex is

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome membraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 4

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Fallopian Tube
66.8 TPM
Ovário
64.6 TPM
Cerebelo
61.1 TPM
Cérebro - Hemisfério cerebelar
58.5 TPM
Pituitária
55.1 TPM
OUTRAS DOENÇAS (6)
peroxisome biogenesis disorder 4Bperoxisome biogenesis disorder 4A (Zellweger)peroxisome biogenesis disorder due to PEX6 defectobsolete Heimler syndrome
HGNC:8859UniProt:Q13608
GJB1Gap junction beta-1 proteinCandidate gene tested inAltamente restrito
FUNÇÃO

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (3)
Oligomerization of connexins into connexonsGap junction assemblyTransport of connexins along the secretory pathway
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, X-linked dominant, 1

A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies characterized by severely reduced motor nerve conduction velocities (NCVs) (less than 38m/s) and segmental demyelination and remyelination, and primary peripheral axonal neuropathies characterized by normal or mildly reduced NCVs and chronic axonal degeneration and regeneration on nerve biopsy. CMTX1 has both demyelinating and axonal features. Central nervous system involvement may occur.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
187.2 TPM
Brain Spinal cord cervical c-1
172.2 TPM
Pâncreas
56.1 TPM
Substância negra
44.4 TPM
Cólon transverso
27.3 TPM
OUTRAS DOENÇAS (2)
Charcot-Marie-Tooth disease X-linked dominant 1X-linked progressive cerebellar ataxia
HGNC:4283UniProt:P08034
SPG7Mitochondrial inner membrane m-AAA protease component parapleginDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic component of the m-AAA protease, a protease that plays a key role in proteostasis of inner mitochondrial membrane proteins, and which is essential for axonal and neuron development (PubMed:11549317, PubMed:28396416, PubMed:31097542, PubMed:9635427). SPG7 possesses both ATPase and protease activities: the ATPase activity is required to unfold substrates, threading them into the internal proteolytic cavity for hydrolysis into small peptide fragments (By similarity). The m-AAA protease ex

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Processing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spastic paraplegia 7, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG7 is a complex form. Additional clinical features are cerebellar syndrome, supranuclear palsy, and cognitive impairment, particularly disturbance of attention and executive functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
63.6 TPM
Cerebelo
50.5 TPM
Cérebro - Hemisfério cerebelar
47.8 TPM
Ovário
47.7 TPM
Cervix Endocervix
43.6 TPM
OUTRAS DOENÇAS (2)
hereditary spastic paraplegia 7lateral sclerosis
HGNC:11237UniProt:Q9UQ90
PNPT1Polyribonucleotide nucleotidyltransferase 1, mitochondrialDisease-causing germline mutation(s) inRestrito
FUNÇÃO

RNA-binding protein implicated in numerous RNA metabolic processes (PubMed:29967381, PubMed:39019044). Catalyzes the phosphorolysis of single-stranded polyribonucleotides processively in the 3'-to-5' direction (PubMed:29967381, PubMed:39019044). Mitochondrial intermembrane factor with RNA-processing exoribonulease activity (PubMed:29967381, PubMed:39019044). Component of the mitochondrial degradosome (mtEXO) complex, that degrades 3' overhang double-stranded RNA with a 3'-to-5' directionality in

LOCALIZAÇÃO

CytoplasmMitochondrion matrixMitochondrion intermembrane space

VIAS BIOLÓGICAS (1)
Mitochondrial RNA degradation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 13

A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
39.7 TPM
Fibroblastos
26.0 TPM
Cérebro - Hemisfério cerebelar
21.3 TPM
Brain Spinal cord cervical c-1
20.7 TPM
Testículo
20.4 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 25combined oxidative phosphorylation defect type 13autosomal recessive nonsyndromic hearing loss 70hearing loss, autosomal recessive
HGNC:23166UniProt:Q8TCS8
CA8Carbonic anhydrase-related proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Does not have a carbonic anhydrase catalytic activity

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 34

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR34 is characterized by congenital cerebellar ataxia associated with dysarthia, quadrupedal gait and intellectual disability.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:1382UniProt:P35219
CSPP1Centrosome and spindle pole-associated protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in cell-cycle-dependent microtubule organization

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCell projection, cilium

MECANISMO DE DOENÇA

Joubert syndrome 21

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
24.0 TPM
Cérebro - Hemisfério cerebelar
10.9 TPM
Fallopian Tube
9.5 TPM
Cervix Endocervix
9.5 TPM
Ovário
9.4 TPM
OUTRAS DOENÇAS (4)
Joubert syndrome 21Joubert syndromeJoubert syndrome with Jeune asphyxiating thoracic dystrophyMeckel syndrome
HGNC:26193UniProt:Q1MSJ5
ITPR1Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Inositol 1,4,5-trisphosphate-gated calcium channel that, upon inositol 1,4,5-trisphosphate binding, mediates calcium release from the endoplasmic reticulum (ER) (PubMed:10620513, PubMed:27108797). Undergoes conformational changes upon ligand binding, suggesting structural flexibility that allows the channel to switch from a closed state, capable of interacting with its ligands such as 1,4,5-trisphosphate and calcium, to an open state, capable of transferring calcium ions across the ER membrane (

LOCALIZAÇÃO

Endoplasmic reticulum membraneCytoplasmic vesicle, secretory vesicle membraneCytoplasm, perinuclear region

VIAS BIOLÓGICAS (10)
Ion homeostasisRegulation of insulin secretionFCGR3A-mediated IL10 synthesisAntigen activates B Cell Receptor (BCR) leading to generation of second messengersCLEC7A (Dectin-1) induces NFAT activation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 15

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
82.0 TPM
Cerebelo
76.2 TPM
Artéria coronária
59.8 TPM
Aorta
52.7 TPM
Fallopian Tube
47.8 TPM
OUTRAS DOENÇAS (3)
aniridia-cerebellar ataxia-intellectual disability syndromespinocerebellar ataxia type 29spinocerebellar ataxia type 15/16
HGNC:6180UniProt:Q14643
SETXHelicase senataxinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

ATP-dependent 5'->3' DNA/RNA helicase that preferentially unwinds RNA substrates over DNA, playing a crucial role in resolving R-loops and promoting transcription termination (PubMed:36864660). Plays a role in transcription regulation by its ability to modulate RNA Polymerase II (Pol II) binding to chromatin and through its interaction with proteins involved in transcription (PubMed:19515850, PubMed:21700224). Contributes to the mRNA splicing efficiency and splice site selection (PubMed:19515850

LOCALIZAÇÃO

NucleusNucleus, nucleoplasmNucleus, nucleolusCytoplasmChromosomeChromosome, telomereCell projection, axonCell projection, growth cone

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN2 is an autosomal recessive form associated with peripheral neuropathy and elevated serum alpha-fetoprotein, immunoglobulins and, less commonly, creatine kinase levels. Some SCAN2 patients manifest oculomotor apraxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
50.4 TPM
Linfócitos
39.4 TPM
Tireoide
36.1 TPM
Baço
32.8 TPM
Pulmão
25.9 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2amyotrophic lateral sclerosis type 4
HGNC:445UniProt:Q7Z333
SNX14Sorting nexin-14Candidate gene tested inTolerante
FUNÇÃO

Plays a role in maintaining normal neuronal excitability and synaptic transmission. May be involved in several stages of intracellular trafficking (By similarity). Required for autophagosome clearance, possibly by mediating the fusion of lysosomes with autophagosomes (Probable). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), a key component of late endosomes/lysosomes (PubMed:25848753). Does not bind phosphatidylinositol 3-phosphate (PtdIns(3P)) (PubMed:25148684, PubMed:25848753)

LOCALIZAÇÃO

Lysosome membraneLate endosome membraneCell projection, dendrite

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 20

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR20 is characterized by cerebellar atrophy, ataxia, coarsened facial features, severely delayed psychomotor development with poor or absent speech, and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
58.2 TPM
Fibroblastos
33.8 TPM
Tireoide
33.7 TPM
Cérebro - Hemisfério cerebelar
32.0 TPM
Linfócitos
31.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 20
HGNC:14977UniProt:Q9Y5W7
BEAN1Protein BEAN1Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Spinocerebellar ataxia 31

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA31 belongs to the autosomal dominant cerebellar ataxias type III (ADCA III) which are characterized by pure cerebellar ataxia without additional signs.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 31
HGNC:24160UniProt:Q3B7T3
TPP1Tripeptidyl-peptidase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Lysosomal serine protease with tripeptidyl-peptidase I activity (PubMed:11054422, PubMed:19038966, PubMed:19038967). May act as a non-specific lysosomal peptidase which generates tripeptides from the breakdown products produced by lysosomal proteinases (PubMed:11054422, PubMed:19038966, PubMed:19038967). Requires substrates with an unsubstituted N-terminus (PubMed:19038966)

LOCALIZAÇÃO

LysosomeMelanosome

VIAS BIOLÓGICAS (1)
XBP1(S) activates chaperone genes
MECANISMO DE DOENÇA

Ceroid lipofuscinosis, neuronal, 2

A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment pattern seen most often in CLN2 consists of curvilinear profiles.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
192.2 TPM
Glândula adrenal
173.0 TPM
Fibroblastos
138.0 TPM
Pulmão
131.9 TPM
Útero
116.5 TPM
OUTRAS DOENÇAS (2)
autosomal recessive spinocerebellar ataxia 7neuronal ceroid lipofuscinosis 2
HGNC:2073UniProt:O14773
ATXN3Ataxin-3Candidate gene tested inTolerante
FUNÇÃO

Deubiquitinating enzyme involved in protein homeostasis maintenance, transcription, cytoskeleton regulation, myogenesis and degradation of misfolded chaperone substrates (PubMed:12297501, PubMed:16118278, PubMed:17696782, PubMed:23625928, PubMed:28445460, PubMed:33157014). Binds long polyubiquitin chains and trims them, while it has weak or no activity against chains of 4 or less ubiquitins (PubMed:17696782). Involved in degradation of misfolded chaperone substrates via its interaction with STUB

LOCALIZAÇÃO

Nucleus matrixNucleusLysosome membrane

VIAS BIOLÓGICAS (2)
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genesJosephin domain DUBs
MECANISMO DE DOENÇA

Spinocerebellar ataxia 3

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA3 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. The molecular defect in SCA3 is the a CAG repeat expansion in ATX3 coding region. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

OUTRAS DOENÇAS (5)
Machado-Joseph diseaseMachado-Joseph disease type 3Machado-Joseph disease type 2Machado-Joseph disease type 1
HGNC:7106UniProt:P54252
MTTPMicrosomal triglyceride transfer protein large subunitCandidate gene tested inTolerante
FUNÇÃO

Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:15897609, PubMed:16478722, PubMed:22236406, PubMed:23475612, PubMed:25108285, PubMed:26224785, PubMed:8876250, PubMed:8939939). Required for the assembly and secretion of plasma lipoproteins that contain apolipoprotein B (PubMed:16478722, PubMed:23475612, PubMed:26224785, PubMed:8876250, PubMed:8939939). May be involved in regulating cholesteryl ester biosynthesis in cells that prod

LOCALIZAÇÃO

Endoplasmic reticulumGolgi apparatus

VIAS BIOLÓGICAS (3)
VLDL assemblyChylomicron assemblyLDL remodeling
MECANISMO DE DOENÇA

Abetalipoproteinemia

An autosomal recessive disorder of lipoprotein metabolism. Affected individuals produce virtually no circulating apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL, lipoprotein(A)). Malabsorption of the antioxidant vitamin E occurs, leading to spinocerebellar and retinal degeneration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
31.1 TPM
Intestino delgado
24.7 TPM
Testículo
7.1 TPM
Ovário
1.8 TPM
Linfócitos
1.2 TPM
OUTRAS DOENÇAS (1)
abetalipoproteinemia
HGNC:7467UniProt:P55157
COA7Cytochrome c oxidase assembly factor 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for assembly of mitochondrial respiratory chain complex I and complex IV

LOCALIZAÇÃO

Mitochondrion intermembrane space

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN3 is an autosomal recessive disorder characterized by onset in the first decade of slowly progressive distal muscle weakness and atrophy and distal sensory impairment due to an axonal peripheral neuropathy. Affected individuals have gait disturbances and sometimes manual dexterity difficulties, as well as cerebellar ataxia associated with cerebellar atrophy on brain imaging.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
HGNC:HGNC:25716UniProt:Q96BR5
NPTX1Neuronal pentraxin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May be involved in mediating uptake of synaptic material during synapse remodeling or in mediating the synaptic clustering of AMPA glutamate receptors at a subset of excitatory synapses

LOCALIZAÇÃO

SecretedCytoplasmic vesicle, secretory vesicleEndoplasmic reticulum

MECANISMO DE DOENÇA

Spinocerebellar ataxia 50

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA50 is an autosomal dominant form characterized by cerebellar ataxia, oculomotor apraxia and other eye movement abnormalities, and cerebellar atrophy on brain imaging.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
444.5 TPM
Cerebelo
405.9 TPM
Brain Frontal Cortex BA9
112.4 TPM
Córtex cerebral
86.9 TPM
Brain Anterior cingulate cortex BA24
57.5 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia 50
HGNC:HGNC:7952UniProt:Q15818
ATP8A2Phospholipid-transporting ATPase IBCandidate gene tested inTolerante
FUNÇÃO

Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids (By similarity). Able to translocate phosphatidylserine, but not phosphatidylcholine (PubMed:34403372). Phospholipid translocation also seems to be implicated in vesicle formation and in uptake of lipid signaling molecules (By similar

LOCALIZAÇÃO

MembraneGolgi apparatus membraneEndosome membraneCell membranePhotoreceptor outer segment membranePhotoreceptor inner segment membrane

VIAS BIOLÓGICAS (1)
Ion transport by P-type ATPases
MECANISMO DE DOENÇA

Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4

An autosomal recessive, congenital cerebellar ataxia associated with dysarthia, quadrupedal gait and intellectual disability.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:13533UniProt:Q9NTI2
CACNA1AVoltage-dependent P/Q-type calcium channel subunit alpha-1ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1A gives rise to P and/or Q-type calcium currents. P/Q-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by the spider omega-agatoxin-IVA

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Presynaptic depolarization and calcium channel openingRegulation of insulin secretion
MECANISMO DE DOENÇA

Spinocerebellar ataxia 6

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA), mainly caused by expansion of a CAG repeat in the coding region of CACNA1A. There seems to be a correlation between the repeat number and earlier onset of the disorder.

OUTRAS DOENÇAS (9)
migraine, familial hemiplegic, 1episodic ataxia type 2developmental and epileptic encephalopathy, 42spinocerebellar ataxia type 6
HGNC:1388UniProt:O00555
RNF168E3 ubiquitin-protein ligase RNF168Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase required for accumulation of repair proteins to sites of DNA damage. Acts with UBE2N/UBC13 to amplify the RNF8-dependent histone ubiquitination. Recruited to sites of DNA damage at double-strand breaks (DSBs) by binding to ubiquitinated histone H2A and H2AX and amplifies the RNF8-dependent H2A ubiquitination, promoting the formation of 'Lys-63'-linked ubiquitin conjugates. This leads to concentrate ubiquitinated histones H2A and H2AX at DNA lesions to the threshold re

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksG2/M DNA damage checkpointProcessing of DNA double-strand break endsNonhomologous End-Joining (NHEJ)SUMOylation of DNA damage response and repair proteins
MECANISMO DE DOENÇA

Riddle syndrome

An autosomal recessive disorder characterized by increased radiosensitivity, immunodeficiency, mild motor control and learning difficulties, facial dysmorphism, and short stature.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
45.1 TPM
Linfócitos
29.6 TPM
Skin Sun Exposed Lower leg
20.0 TPM
Cervix Ectocervix
19.6 TPM
Skin Not Sun Exposed Suprapubic
18.6 TPM
OUTRAS DOENÇAS (1)
RIDDLE syndrome
HGNC:26661UniProt:Q8IYW5
KIF1CKinesin-like protein KIF1CDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end-directed motility

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (2)
KinesinsCOPI-dependent Golgi-to-ER retrograde traffic
MECANISMO DE DOENÇA

Spastic ataxia 2, autosomal recessive

A neurologic disorder characterized by cerebellar ataxia, dysarthria, and variable spasticity of the lower limbs. Cognition is not affected.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
308.2 TPM
Brain Spinal cord cervical c-1
252.4 TPM
Substância negra
164.6 TPM
Artéria tibial
160.2 TPM
Aorta
151.4 TPM
OUTRAS DOENÇAS (1)
spastic ataxia 2
HGNC:6317UniProt:O43896
SPTBN2Spectrin beta chain, non-erythrocytic 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Probably plays an important role in neuronal membrane skeleton

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cell cortex

VIAS BIOLÓGICAS (5)
RAF/MAP kinase cascadeNCAM signaling for neurite out-growthCOPI-mediated anterograde transportInteraction between L1 and AnkyrinsMHC class II antigen presentation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 5

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA5 is an autosomal dominant cerebellar ataxia (ADCA). It is a slowly progressive disorder with variable age at onset, ranging between 10 and 50 years.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
153.6 TPM
Skin Sun Exposed Lower leg
116.8 TPM
Cérebro - Hemisfério cerebelar
113.8 TPM
Testículo
110.1 TPM
Skin Not Sun Exposed Suprapubic
102.0 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 5autosomal recessive spinocerebellar ataxia 14
HGNC:11276UniProt:O15020
PUM1Pumilio homolog 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Sequence-specific RNA-binding protein that acts as a post-transcriptional repressor by binding the 3'-UTR of mRNA targets. Binds to an RNA consensus sequence, the Pumilio Response Element (PRE), 5'-UGUANAUA-3', that is related to the Nanos Response Element (NRE) (PubMed:18328718, PubMed:21397187, PubMed:21572425, PubMed:21653694). Mediates post-transcriptional repression of transcripts via different mechanisms: acts via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational

LOCALIZAÇÃO

CytoplasmCytoplasm, P-bodyCytoplasmic granule

VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism

An autosomal dominant disorder characterized by global developmental delay, impaired intellectual development, early-onset seizures, poor overall growth, delayed walking, hypotonia and/or ataxia, and facial dysmorphism. Some patients have hypoplasia of the corpus callosum and cerebral atrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
56.0 TPM
Ovário
54.0 TPM
Nervo tibial
52.9 TPM
Artéria tibial
52.6 TPM
Cérebro - Hemisfério cerebelar
51.0 TPM
OUTRAS DOENÇAS (2)
neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphismspinocerebellar ataxia 47
HGNC:14957UniProt:Q14671
ATXN1Ataxin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression. Binds RNA in vitro. May be involved in RNA metabolism (PubMed:21475249). In concert with CIC and ATXN1L, involved in brain development (By similarity)

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Spinocerebellar ataxia 1

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 1
HGNC:10548UniProt:P54253
GLRX5Glutaredoxin-related protein 5, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Monothiol glutaredoxin involved in mitochondrial iron-sulfur (Fe/S) cluster transfer (PubMed:20364084, PubMed:23615440). Receives 2Fe/2S clusters from scaffold protein ISCU and mediates their transfer to apoproteins, to the 4Fe/FS cluster biosynthesis machinery, or export from mitochondrion (PubMed:20364084, PubMed:23615440, PubMed:24334290). Required for normal regulation of hemoglobin synthesis by the iron-sulfur protein ACO1 (PubMed:20364084)

LOCALIZAÇÃO

Mitochondrion matrix

VIAS BIOLÓGICAS (1)
Mitochondrial iron-sulfur cluster biogenesis
MECANISMO DE DOENÇA

Anemia, sideroblastic, 3, pyridoxine-refractory

A form of sideroblastic anemia, a bone marrow disorder defined by the presence of pathologic iron deposits in erythroblast mitochondria. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus. SIDBA3 is refractory to treatment with vitamin B6, while iron chelation therapy may result in clinical improvement. SIDBA3 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
65.0 TPM
Glândula adrenal
55.8 TPM
Músculo esquelético
48.2 TPM
Ovário
43.3 TPM
Rim - Medula
42.5 TPM
OUTRAS DOENÇAS (2)
spasticity-ataxia-gait anomalies syndromesideroblastic anemia 3
HGNC:20134UniProt:Q86SX6
ATP1A3Sodium/potassium-transporting ATPase subunit alpha-3Candidate gene tested inAltamente restrito
FUNÇÃO

This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Dystonia 12

An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.

OUTRAS DOENÇAS (6)
developmental and epileptic encephalopathy 99cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromedystonia 12alternating hemiplegia of childhood 2
HGNC:801UniProt:P13637
RUBCNRun domain Beclin-1-interacting and cysteine-rich domain-containing proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Inhibits PIK3C3 activity; under basal conditions negatively regulates PI3K complex II (PI3KC3-C2) function in autophagy. Negatively regulates endosome maturation and degradative endocytic trafficking and impairs autophagosome maturation process. Can sequester UVRAG from association with a class C Vps complex (possibly the HOPS complex) and negatively regulates Rab7 activation (PubMed:20974968, PubMed:21062745) Involved in regulation of pathogen-specific host defense of activated macrophages. Fol

LOCALIZAÇÃO

Late endosomeLysosomeEarly endosome

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 15

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR15 patients manifest cerebellar ataxia in early childhood and delayed motor development with delayed walking. Additional features include dysarthria, upper limb involvement, abnormal eye movements, and hyporeflexia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
38.4 TPM
Cérebro - Hemisfério cerebelar
34.0 TPM
Cerebelo
30.9 TPM
Testículo
27.1 TPM
Baço
26.4 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 15
HGNC:28991UniProt:Q92622
DAB1Disabled homolog 1Candidate gene tested inAltamente restrito
FUNÇÃO

Signaling adapter of the reelin-mediated signaling pathway, which regulates the migration and differentiation of postmitotic neurons during brain development. Mediates intracellular transduction of Reelin signaling following reelin (RELN)-binding to its receptor: acts by docking proteins through its phosphotyrosine residues and PID domain

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Reelin signalling pathway
MECANISMO DE DOENÇA

Spinocerebellar ataxia 37

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA37 is an autosomal dominant form characterized by adult-onset of slowly progressive gait instability, frequent falls, and dysarthria associated with cerebellar atrophy on brain imaging.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
23.7 TPM
Cerebelo
19.4 TPM
Nervo tibial
7.7 TPM
Hipocampo
5.0 TPM
Brain Anterior cingulate cortex BA24
4.7 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 37
HGNC:2661UniProt:O75553
CEP41Centrosomal protein of 41 kDaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required during ciliogenesis for tubulin glutamylation in cilium. Probably acts by participating in the transport of TTLL6, a tubulin polyglutamylase, between the basal body and the cilium

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, ciliumCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 15

An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly.

OUTRAS DOENÇAS (3)
Joubert syndrome 15Joubert syndromeJoubert syndrome with ocular defect
HGNC:12370UniProt:Q9BYV8
MKS1Tectonic-like complex member MKS1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Involved in centrosome migration to the apical cell surface during early ciliogenesis. Required for ciliary structure and function, including a role in regulating length and appropriate number through modulating centrosome duplication. Required for cell branching morphology

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 1

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
24.3 TPM
Ovário
22.3 TPM
Útero
20.0 TPM
Cervix Endocervix
18.8 TPM
Pituitária
18.7 TPM
OUTRAS DOENÇAS (7)
Joubert syndrome 28Bardet-Biedl syndrome 13Meckel syndrome, type 1Joubert syndrome
HGNC:7121UniProt:Q9NXB0
DNMT1DNA (cytosine-5)-methyltransferase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

DNA methyltransferase that methylates CpG residues (PubMed:17200670, PubMed:18754681, PubMed:21745816, PubMed:26070743). Preferentially methylates hemimethylated DNA (PubMed:21745816, PubMed:26070743). Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is essential for epigenetic inheritance (PubMed:17200670, PubMed:21745816). Associates with chromatin during G2 and M phases to maintain DNA methylation independently of repli

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (7)
STAT3 nuclear events downstream of ALK signalingNuclear events stimulated by ALK signaling in cancerDefective pyroptosisPRC2 methylates histones and DNADNA methylation
MECANISMO DE DOENÇA

Neuropathy, hereditary sensory, 1E

A neurodegenerative disorder characterized by adult onset of progressive peripheral sensory loss associated with progressive hearing impairment and early-onset dementia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
84.0 TPM
Testículo
56.6 TPM
Cérebro - Hemisfério cerebelar
54.8 TPM
Cerebelo
53.6 TPM
Fibroblastos
46.5 TPM
OUTRAS DOENÇAS (2)
autosomal dominant cerebellar ataxia, deafness and narcolepsyhereditary sensory neuropathy-deafness-dementia syndrome
HGNC:2976UniProt:P26358
CAMTA1Calmodulin-binding transcription activator 1Candidate gene tested inAltamente restrito
FUNÇÃO

Transcriptional activator

LOCALIZAÇÃO

NucleusCytoplasm

MECANISMO DE DOENÇA

Cerebellar dysfunction with variable cognitive and behavioral abnormalities

An autosomal dominant neurodevelopmental disorder characterized by mildly delayed psychomotor development, early onset of cerebellar ataxia, and intellectual disability later in childhood and adult life. Other features may include neonatal hypotonia, dysarthria, and dysmetria. Brain imaging in some patients shows cerebellar atrophy. Dysmorphic facial features are variable.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
cerebellar dysfunction with variable cognitive and behavioral abnormalitiesepithelioid hemangioendothelioma
HGNC:18806UniProt:Q9Y6Y1
TMEM240Transmembrane protein 240Disease-causing germline mutation(s) inAltamente restrito
LOCALIZAÇÃO

SynapseCell membrane

MECANISMO DE DOENÇA

Spinocerebellar ataxia 21

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA21 is characterized by onset in the first decades of life of slowly progressive relatively mild cerebellar ataxia associated with slight extrapyramidal features predominant in older patients and cognitive impairment predominant in younger patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
59.7 TPM
Cerebelo
57.9 TPM
Brain Frontal Cortex BA9
28.4 TPM
Córtex cerebral
26.7 TPM
Brain Nucleus accumbens basal ganglia
22.9 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 21
HGNC:25186UniProt:Q5SV17
CCDC88CProtein DapleCandidate gene tested inTolerante
FUNÇÃO

Required for activation of guanine nucleotide-binding proteins (G-proteins) during non-canonical Wnt signaling (PubMed:26126266). Binds to ligand-activated Wnt receptor FZD7, displacing DVL1 from the FZD7 receptor and leading to inhibition of canonical Wnt signaling (PubMed:26126266). Acts as a non-receptor guanine nucleotide exchange factor by also binding to guanine nucleotide-binding protein G(i) alpha (Gi-alpha) subunits, leading to their activation (PubMed:26126266). Binding to Gi-alpha sub

LOCALIZAÇÃO

CytoplasmCell junction

VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by DVL-interacting proteins
MECANISMO DE DOENÇA

Hydrocephalus, congenital, 1

A form of congenital hydrocephalus, a disease characterized by onset in utero of enlarged ventricles due to accumulation of ventricular cerebrospinal fluid. Affected individuals may have neurologic impairment. HYC1 inheritance is autosomal recessive.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
hydrocephalus, nonsyndromic, autosomal recessive 1spinocerebellar ataxia type 40congenital non-communicating hydrocephalus
HGNC:19967UniProt:Q9P219
TMEM138Transmembrane protein 138Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for ciliogenesis

LOCALIZAÇÃO

Vacuole membraneCell projection, cilium

MECANISMO DE DOENÇA

Joubert syndrome 16

An autosomal recessive disorder characterized by oculomotor apraxia, variable coloboma, and rare kidney involvement. Neuroradiologically, it is characterized by an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
46.1 TPM
Ovário
37.6 TPM
Fallopian Tube
34.8 TPM
Útero
32.5 TPM
Cervix Endocervix
31.2 TPM
OUTRAS DOENÇAS (2)
Joubert syndrome 16Joubert syndrome with oculorenal defect
HGNC:26944UniProt:Q9NPI0
TBCETubulin-specific chaperone ECandidate gene tested inTolerante
FUNÇÃO

Tubulin-folding protein; involved in the second step of the tubulin folding pathway and in the regulation of tubulin heterodimer dissociation. Required for correct organization of microtubule cytoskeleton and mitotic splindle, and maintenance of the neuronal microtubule network

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Post-chaperonin tubulin folding pathway
MECANISMO DE DOENÇA

Hypoparathyroidism-retardation-dysmorphism syndrome

An autosomal recessive multisystem disorder characterized by hypoparathyroidism, intrauterine and postnatal growth retardation, psychomotor retardation, epilepsy, microcephaly, and facial dysmorphism.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
38.8 TPM
Cérebro - Hemisfério cerebelar
35.3 TPM
Fibroblastos
31.5 TPM
Artéria tibial
31.4 TPM
Cerebelo
31.3 TPM
OUTRAS DOENÇAS (4)
autosomal recessive Kenny-Caffey syndromeencephalopathy, progressive, with amyotrophy and optic atrophyhypoparathyroidism-retardation-dysmorphism syndromeearly-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome
HGNC:11582UniProt:Q15813
AFG3L2Mitochondrial inner membrane m-AAA protease component AFG3L2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic component of the m-AAA protease, a protease that plays a key role in proteostasis of inner mitochondrial membrane proteins, and which is essential for axonal and neuron development (PubMed:19748354, PubMed:28396416, PubMed:29932645, PubMed:30683687, PubMed:31327635, PubMed:37917749, PubMed:38157846). AFG3L2 possesses both ATPase and protease activities: the ATPase activity is required to unfold substrates, threading them into the internal proteolytic cavity for hydrolysis into small pe

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Processing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 28

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA28 is an autosomal dominant cerebellar ataxia (ADCA) with a slow progressive course and no evidence of sensory involvement or cognitive impairment.

OUTRAS DOENÇAS (3)
optic atrophy 12spinocerebellar ataxia type 28spastic ataxia 5
HGNC:315UniProt:Q9Y4W6
CTDP1RNA polymerase II subunit A C-terminal domain phosphataseCandidate gene tested inTolerante
FUNÇÃO

Processively dephosphorylates 'Ser-2' and 'Ser-5' of the heptad repeats YSPTSPS in the C-terminal domain of the largest RNA polymerase II subunit. This promotes the activity of RNA polymerase II. Plays a role in the exit from mitosis by dephosphorylating crucial mitotic substrates (USP44, CDC20 and WEE1) that are required for M-phase-promoting factor (MPF)/CDK1 inactivation

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle poleMidbody

VIAS BIOLÓGICAS (10)
TP53 Regulates Transcription of DNA Repair GenesFormation of HIV elongation complex in the absence of HIV TatFormation of the HIV-1 Early Elongation ComplexAbortive elongation of HIV-1 transcript in the absence of TatFormation of HIV-1 elongation complex containing HIV-1 Tat
MECANISMO DE DOENÇA

Congenital cataracts, facial dysmorphism, and neuropathy

An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
34.3 TPM
Skin Sun Exposed Lower leg
22.0 TPM
Skin Not Sun Exposed Suprapubic
18.4 TPM
Sangue
17.1 TPM
Baço
16.3 TPM
OUTRAS DOENÇAS (1)
congenital cataracts-facial dysmorphism-neuropathy syndrome
HGNC:2498UniProt:Q9Y5B0
ATG7Ubiquitin-like modifier-activating enzyme ATG7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E1-like activating enzyme involved in the 2 ubiquitin-like systems required for cytoplasm to vacuole transport (Cvt) and autophagy. Activates ATG12 for its conjugation with ATG5 as well as the ATG8 family proteins for their conjugation with phosphatidylethanolamine. Both systems are needed for the ATG8 association to Cvt vesicles and autophagosomes membranes. Required for autophagic death induced by caspase-8 inhibition. Facilitates LC3-I lipidation with phosphatidylethanolamine to form LC3-II w

LOCALIZAÇÃO

CytoplasmPreautophagosomal structure

VIAS BIOLÓGICAS (3)
MacroautophagyAntigen processing: Ubiquitination & Proteasome degradationDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 31

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR30 is characterized by global developmental delay, hypotonia, variably impaired intellectual and language development, ataxic gait, tremor, and dysarthria. Most affected individuals have optic atrophy. Additional features may include retinitis pigmentosa, sensorineural deafness, dysmorphic facial features, and possibly endocrine dysfunction.

OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 31
HGNC:HGNC:16935UniProt:O95352
PLEKHG4Puratrophin-1Candidate gene tested inTolerante
FUNÇÃO

Possible role in intracellular signaling and cytoskeleton dynamics at the Golgi

LOCALIZAÇÃO

VIAS BIOLÓGICAS (3)
RAC1 GTPase cycleCDC42 GTPase cycleRHOA GTPase cycle
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
78.0 TPM
Ovário
30.6 TPM
Fibroblastos
23.8 TPM
Nervo tibial
17.9 TPM
Mama
14.2 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia type 4
HGNC:24501UniProt:Q58EX7

Variantes genéticas (ClinVar)

821 variantes patogênicas registradas no ClinVar.

🧬 RPGRIP1L: NM_015272.5(RPGRIP1L):c.3508del (p.Gln1170fs) ()
🧬 RPGRIP1L: NM_015272.5(RPGRIP1L):c.3266del (p.Pro1089fs) ()
🧬 RPGRIP1L: NM_015272.5(RPGRIP1L):c.2975del (p.Pro992fs) ()
🧬 RPGRIP1L: NM_015272.5(RPGRIP1L):c.435C>G (p.Tyr145Ter) ()
🧬 RPGRIP1L: NM_015272.5(RPGRIP1L):c.17A>G (p.Asp6Gly) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 80 variantes classificadas pelo ClinVar.

8
64
8
Patogênica (10.0%)
VUS (80.0%)
Benigna (10.0%)
VARIANTES MAIS SIGNIFICATIVAS
PRKCG: NM_002739.5(PRKCG):c.344A>T (p.Asp115Val) [Likely pathogenic]
TTBK2: NM_173500.4(TTBK2):c.2479A>G (p.Lys827Glu) [Conflicting classifications of pathogenicity]
WASF1: NM_003931.3(WASF1):c.809G>T (p.Arg270Met) [Uncertain significance]
RANBP2: NM_006267.5(RANBP2):c.7850-1G>A [Uncertain significance]
ABCD1: NM_000033.4(ABCD1):c.679T>C (p.Tyr227His) [Uncertain significance]

Vias biológicas (Reactome)

173 vias biológicas associadas aos genes desta condição.

Hedgehog 'off' state Anchoring of the basal body to the plasma membrane Nuclear signaling by ERBB4 Negative regulation of activity of TFAP2 (AP-2) family transcription factors Activation of the TFAP2 (AP-2) family of transcription factors RNU12 gene U12 snRNA U1,U2,U4,U4atac,U5,U11,U12 gene Reelin signalling pathway VLDLR internalisation and degradation VLDL clearance Opioid Signalling G-protein activation Peptide ligand-binding receptors G alpha (i) signalling events Glycerophospholipid catabolism Translocation of SLC2A4 (GLUT4) to the plasma membrane Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane Gap junction assembly MHC class II antigen presentation Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Recruitment of NuMA to mitotic centrosomes Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Post-chaperonin tubulin folding pathway Recycling pathway of L1 Cargo trafficking to the periciliary membrane Intraflagellar transport RHO GTPases activate IQGAPs RHO GTPases Activate Formins COPI-mediated anterograde transport COPI-dependent Golgi-to-ER retrograde traffic COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase The role of GTSE1 in G2/M progression after G2 checkpoint Carboxyterminal post-translational modifications of tubulin HCMV Early Events Assembly and cell surface presentation of NMDA receptors Activation of AMPK downstream of NMDARs Aggrephagy EML4 and NUDC in mitotic spindle formation Sealing of the nuclear envelope (NE) by ESCRT-III Kinesins E3 ubiquitin ligases ubiquitinate target proteins Peroxisomal protein import G alpha (q) signalling events Class C/3 (Metabotropic glutamate/pheromone receptors) Neurexins and neuroligins Sensory perception of sweet, bitter, and umami (glutamate) taste tRNA modification in the nucleus and cytosol Phase 0 - rapid depolarisation Regulation of PTEN gene transcription Voltage gated Potassium channels Phase 1 - inactivation of fast Na+ channels Stimuli-sensing channels Induction of Cell-Cell Fusion Peptide chain elongation Uptake and function of diphtheria toxin Synthesis of diphthamide-EEF2 Neutrophil degranulation Protein methylation CYFIP2 CYFIP1 CYFIP1 CYFIP1 CYFIP1 CYFIP1 Cytosolic sensors of pathogen-associated DNA RNA Polymerase III Chain Elongation RNA Polymerase III Transcription Termination RNA Polymerase III Abortive And Retractive Initiation RNA Polymerase III Transcription Initiation From Type 1 Promoter RNA Polymerase III Transcription Initiation From Type 2 Promoter RNA Polymerase III Transcription Initiation From Type 3 Promoter Transcriptional activation of mitochondrial biogenesis Mitochondrial protein degradation Strand-asynchronous mitochondrial DNA replication APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway Mitochondrial protein import NCAM1 interactions Smooth Muscle Contraction Regulation of TP53 Activity through Association with Co-factors Mitochondrial tRNA aminoacylation NKX6-1 NKX6-1 mRNA NKX6-1 gene PDX1-dependent synthesis of NKX6-1 protein PDX1-dependent synthesis of NKX6-1 protein Duodeno-pancreatic endoderm cell produces primary multipotent pancreatic progenitor cell Ventral foregut endoderm cell produces primary multipotent pancreatic progenitor cell Primary multipotent pancreatic progenitor cell produces trunk bipotent pancreatic progenitor cell Pancreatic tip progenitor cell produces pancreatic pro-acinar cell Primary multipotent pancreatic progenitor cell produces pancreatic tip progenitor cell Pancreatic pro-acinar cell produces pancreatic acinar cell Mitochondrial iron-sulfur cluster biogenesis Maturation of TCA enzymes and regulation of TCA cycle Complex III assembly Hyaluronan degradation Sodium/Proton exchangers Processing of SMDT1 Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome AURKA Activation by TPX2 Synthesis of very long-chain fatty acyl-CoAs Nonhomologous End-Joining (NHEJ) Oligomerization of connexins into connexons Transport of connexins along the secretory pathway Mitochondrial RNA degradation PLC beta mediated events Effects of PIP2 hydrolysis Elevation of cytosolic Ca2+ levels DAG and IP3 signaling Role of phospholipids in phagocytosis FCERI mediated Ca+2 mobilization Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Ca2+ pathway cGMP effects Regulation of insulin secretion VEGFR2 mediated cell proliferation Ion homeostasis CLEC7A (Dectin-1) induces NFAT activation FCGR3A-mediated IL10 synthesis Antigen activates B Cell Receptor (BCR) leading to generation of second messengers XBP1(S) activates chaperone genes Josephin domain DUBs FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes VLDL assembly Chylomicron assembly LDL remodeling Ion transport by P-type ATPases Presynaptic depolarization and calcium channel opening SUMOylation of DNA damage response and repair proteins Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Processing of DNA double-strand break ends G2/M DNA damage checkpoint NCAM signaling for neurite out-growth Interaction between L1 and Ankyrins RAF/MAP kinase cascade Golgi Associated Vesicle Biogenesis Potential therapeutics for SARS PRC2 methylates histones and DNA NoRC negatively regulates rRNA expression SUMOylation of DNA methylation proteins DNA methylation STAT3 nuclear events downstream of ALK signaling Defective pyroptosis Nuclear events stimulated by ALK signaling in cancer Negative regulation of TCF-dependent signaling by DVL-interacting proteins Formation of RNA Pol II elongation complex Formation of the Early Elongation Complex Formation of HIV elongation complex in the absence of HIV Tat Formation of the HIV-1 Early Elongation Complex Formation of HIV-1 elongation complex containing HIV-1 Tat Pausing and recovery of Tat-mediated HIV elongation Abortive elongation of HIV-1 transcript in the absence of Tat Tat-mediated HIV elongation arrest and recovery Tat-mediated elongation of the HIV-1 transcript HIV elongation arrest and recovery Pausing and recovery of HIV elongation RNA Polymerase II Pre-transcription Events TP53 Regulates Transcription of DNA Repair Genes RNA Polymerase II Transcription Elongation Macroautophagy Signaling by BRAF and RAF1 fusions Antigen processing: Ubiquitination & Proteasome degradation Dengue Virus Attachment and Entry RHOA GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 22
·Pré-clínico9
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 11 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ataxia hereditária

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

13 ensaios clínicos encontrados, 3 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
237 papers (10 anos)
#1

Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review.

International journal of molecular sciences2026 Jan 15

Hereditary ataxias are a heterogeneous group of disorders with overlapping clinical presentations but diverse genetic and molecular etiologies. Biomarkers are increasingly essential to improve diagnosis, refine prognosis, and accelerate the development of targeted therapies. Following PRISMA-ScR guidelines, we conducted a scoping review of PubMed and complementary sources (2010-2025) to map and describe the current landscape of genetic, imaging, fluid, electrophysiological, and digital biomarkers across the most prevalent hereditary ataxias, including SCA1, SCA2, SCA3, SCA6, SCA7, SCA17, SCA27B, dentatorubral-pallidoluysian atrophy (DRPLA), Friedreich's ataxia (FRDA), RFC1-related ataxia (CANVAS), SPG7, and fragile X-associated tremor/ataxia syndrome (FXTAS). Eligible evidence encompassed observational cohorts, clinical trials, case series, and case reports providing primary biomarker data, with the objective of characterizing evidence breadth and identifying knowledge gaps rather than assessing comparative effectiveness. Across modalities, converging evidence highlights subtype-specific biomarker signatures. MRI volumetry, DTI, and FDG-PET map characteristic neurodegeneration patterns. Fluid biomarkers such as neurofilament light chain are informative across several SCAs and FRDA, while frataxin levels constitute robust endpoints in FRDA trials. Pathology-specific biomarkers such as ataxin-3 are advancing as tools for target engagement and may generalize to future gene-lowering strategies. Electrophysiological and oculographic measures show sensitivity for early disease detection, and wearable technologies are emerging as scalable tools for longitudinal monitoring. This scoping review synthesizes the heterogeneous evidence on hereditary ataxia biomarkers, highlighting multimodal frameworks that link molecular mechanisms with clinical endpoints. Mapping current approaches also reveals substantial variability and gaps across diseases and modalities, underscoring the need for harmonized validation in international multicenter cohorts and systematic integration into future clinical trials to advance precision medicine in hereditary ataxias.

#2

Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxia.

Molecular therapy : the journal of the American Society of Gene Therapy2026 Feb 04

Friedreich's ataxia (FA) is a leading form of hereditary ataxia caused by autosomal recessive mutations in frataxin (FXN). GAA triplet repeat expansions lead to lower levels of FXN expression, abnormal influx of iron into mitochondria, and damage to the nervous system. Patients typically present before the second decade with loss of muscular function, speech impediments, and cardiomyopathy. At later stages, vision loss typically manifests. Work is under way to develop gene therapies that address the cardiac and CNS manifestations, but their routes of administration do not lead to efficient transduction of the retina. The purpose of this study was to develop a more direct approach for treating the ocular phenotype of FA, which includes loss of retinal ganglion cells (RGCs), thinning of the retinal nerve fiber layer, optic nerve atrophy, and loss of visual field. We generated two novel conditional knockout (KO) models, mRx-Fxn KO and Pou4f2-Fxn KO mice, wherein Fxn is ablated in all retinal cells or RGCs, respectively, and showed that FXN deficiency led to retinal dystrophy in both models. Gene supplementation via intravitreal injection of a novel AAV2-based capsid carrying FXN partially preserved retinal structure and/or function in both models, establishing proof of concept for this therapeutic strategy.

#3

Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.

Brain : a journal of neurology2026 Mar 05

Hereditary adult-onset ataxias are a heterogeneous group of phenotypically overlapping conditions, often caused by pathogenic expansions of short tandem repeats. Currently, 18 repeat disorders with a core phenotype of adult-onset ataxia are known. Diagnosis typically relies on sequential PCR-based methods, which are labour-intensive and lack precision. Long-read sequencing (LRS) has the potential to overcome these limitations and is currently implemented and validated in clinical genetics. Using clinical nanopore Cas9-targeted sequencing (Clin-CATS) for parallel in-depth repeat analysis, we evaluated a diagnostic cohort of 513 adult-onset ataxia patients, determining frequencies of all known repeat-associated ataxias except Spinocerebellar ataxia 4 (SCA4), as well as the carrier frequencies for autosomal-recessive disorders, RFC1 spectrum disorder and Friedreich's ataxia (FRDA). Additionally, phenotypes of patients with established genetic diagnoses were characterized, especially those of patients living with RFC1 spectrum disorder and SCA27B. Repeat-associated ataxias were confirmed in 33.3% of cases, including rare ataxias, such as SCA10, SCA36 and SCA37, alongside as the most prevalent conditions SCA27B and RFC1 spectrum disorder. Potentially pathogenic expansions in FGF14 were identified in an additional 4.7% of patients. Testing of another 347 patients for ZFHX3 expansions linked to SCA4 did not identify any cases. Dual diagnoses were frequent, occurring in 6.4% of patients with repeat-associated ataxia. We confirmed a high RFC1 spectrum disorder carrier frequency (7.2%) and reclassified certain FXN expansions as likely non-pathogenic, resulting in a lower than estimated carrier frequency for FRDA of 0.8%. We also identified novel repeat configurations in several loci and illustrated the high heterogeneity of repeat expansions in RFC1, highlighting it as a potential source of false results when using PCR-based methods. This study underscores the diagnostic advantages of LRS for comprehensive repeat analysis and recommends its adoption as a standard in clinical genetics, replacing Southern blot and PCR-based approaches. Furthermore, based on our findings in a large patient cohort a re-evaluation of existing phenotype-genotype correlations is recommended as well as evaluating additional parameters alongside the repeat length to improve diagnostic precision of repeat analysis.

#4

Clinical and genetic diagnostic challenges in presumed hereditary ataxia.

Journal of neurology2026 Mar 23
#5

Exploring the Potential of Scales to Assess Different Types of Ataxia: Meta-review.

Cerebellum (London, England)2026 Mar 13

Ataxia is a coordination disorder that encompasses more than 300 neurological diseases and more than 200 types of hereditary ataxia. Depending on the pathology with which it is associated, the symptomatology present is different: balance and gait disturbance, dysdiadochokinesia, dysarthria, nystagmus, etc. Due to this heterogeneity, the assessment of ataxia is a complex task that is further hindered by the broad variety of existing tools, both specific to ataxia and related to a particular pathology, such as those that assess coordination and gait components. Analyse, organize and compare the structural and psychometric characteristics of the tools used for the assessment of different types of ataxia. A meta-review registered in PROSPERO was conducted following the PRISMA Checklist System. Six database were used and two blinded researchers selected the papers according the criteria. Five reviews were included in this study. The main psychometric properties of the 16 scales found to assess ataxia symptoms in different pathologies were analysed. Internal consistency and reliability obtained good-to-excellent values for the total score of the different scales and parameters studied. However, validity and sensitivity showed less homogeneous values. The scales that globally assess the severity of the disease stand out, with a great variety of scales, including the International Cooperative Ataxia Assessment Scale (ICARS) and the Scale for the Assessment and Rating of Ataxias (SARA) as the most widely used.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC199 artigos no totalmostrando 195

2026

Clinical and genetic diagnostic challenges in presumed hereditary ataxia.

Journal of neurology
2026

Exploring the Potential of Scales to Assess Different Types of Ataxia: Meta-review.

Cerebellum (London, England)
2026

Quantifying Placebo Effects in Hereditary Ataxia Trials: A Meta-Analysis of Scale for the Assessment and Rating of Ataxia (SARA) Score Changes.

Movement disorders : official journal of the Movement Disorder Society
2026

Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review.

International journal of molecular sciences
2026

Genetic testing for adult-onset neurodegenerative diseases: A clinical perspective.

Journal of the Formosan Medical Association = Taiwan yi zhi
2025

Identification of a Novel CLPX Variant in a Mixed-Breed Dog with Anemia and Spinocerebellar Ataxia.

Genes
2025

Purkinje cell development and degeneration in the spastic Han-Wistar rat model of ataxia.

Research square
2025

Ataxia, intentional tremor and hypotonia syndrome caused by a novel POU4F1 gene mutation: a case report.

Frontiers in genetics
2026

Multidimensional abnormal gait analysis and biomarker identification for patients with spinocerebellar ataxia type 3 using an Azure Kinect-based motion capture system.

Gait &amp; posture
2026

Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxia.

Molecular therapy : the journal of the American Society of Gene Therapy
2025

Ataxia with oculomotor apraxia type 2: two pedigree studies and a comprehensive review.

Journal of neurology
2025

Friedreich's Ataxia in Colombia: A Population-Based Study of Incidence and Socioeconomic Determinants.

Movement disorders : official journal of the Movement Disorder Society
2026

Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.

Brain : a journal of neurology
2025

Practice Recommendations for Genetic Testing of Ataxias.

Annals of clinical and translational neurology
2025

Best Oculomotor Endpoints for Clinical Trials in Hereditary Ataxias: A Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital‑Motor Biomarkers.

Cerebellum (London, England)
2025

Three-Week Video- and Home-Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial.

Movement disorders clinical practice
2025

Clinical and genetic analysis of a case series of 12 Chinese families with hereditary ataxia.

Frontiers in neurology
2025

FGF14 (GAA∙TTC) repeat expansion-related ataxia SCA27B is common in Northern Finland.

Parkinsonism &amp; related disorders
2025

Publisher Correction: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.

Nature medicine
2025

Autosomal Recessive Cerebellar Ataxia-27 Caused by a Novel Loss-of-Function Variant of Ganglioside-Induced Differentiation Associated Protein 2 in a Spanish Family.

Neurology. Genetics
2025

Base editing of trinucleotide repeats that cause Huntington's disease and Friedreich's ataxia reduces somatic repeat expansions in patient cells and in mice.

Nature genetics
2025

Dietary and lifestyle interventions for the management of hereditary ataxias.

Frontiers in nutrition
2025

Clinical Characteristics of Spinocerebellar Ataxia Type 3 in Uruguay.

Cerebellum (London, England)
2025

The molecular landscape of hereditary ataxia: a single-center study.

Human genetics
2025

Hereditary Ataxias in Argentina.

Cerebellum (London, England)
2025

Novel KIF1A Variant in a Patient with Cerebellar Atrophy and Ataxia: A Case Report.

Cerebellum (London, England)
2025

Pendular Nystagmus: a Novel Feature of ANO10-Related Disorders.

Cerebellum (London, England)
2025

The Spectrum of Peripheral-Vestibular Deficits and Their Change Over Time in CANVAS/RFC1-Related Ataxia Systematic Review and Meta-Analysis of Quantitative Head-Impulse Testing.

Cerebellum (London, England)
2025

Autosomal Recessive Ataxias in Northeast Brazil: A Regional Multicenter Case Series.

Cerebellum (London, England)
2025

Rapid Recovery From Bell's Palsy Using Transcranial Magnetic Stimulation of the Facial Nerve: A Case Report.

Cureus
2025

Ide Copy Number Variant Does Not Influence Stroke Severity in 2 C57BL/6J Mouse Models nor in Humans: An Exploratory Study.

Stroke
2025

Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.

Nature medicine
2024

Quantitative Oculomotor and Vestibular Profile in Spinocerebellar Ataxia Type 6 - Systematic Review and Meta-Analysis.

Cerebellum (London, England)
2025

A Population-Wide Exploration of the THAP11 CAG Repeat Size and Structure in the 100,000 Genomes Project and UK Biobank.

Movement disorders : official journal of the Movement Disorder Society
2024

Hereditary Spastic Paraplegia Associated with Ultra-Rare Variant Enrichment Encompassing the SYNE1, CAPN1 and PGAP1 Genes.

Cerebellum (London, England)
2024

Bilateral Dentate Nuclei Hyperintensities and Response to 4-Aminopyridine in a Patient With Childhood-Onset GAA-FGF14-Related Ataxia.

Neurology. Genetics
2025

Uniparental IsoDisomy: a case study on a new mechanism of Friedreich ataxia.

European journal of human genetics : EJHG
2024

[Self-assessed use and provision of assistive devices in individuals with hereditary ataxia at the interface between development in childhood and adolescence and symptom progression].

Die Rehabilitation
2025

Efficacy and Safety of Taltirelin Hydrate in Patients With Ataxia Due to Spinocerebellar Degeneration.

Journal of movement disorders
2025

Spinocerebellar Ataxia Type 27B (SCA27B): A Hereditary Ataxia in Portugal.

Acta medica portuguesa
2024

Efficacy and safety of riluzole for treating motor function in rare dyskinesia syndromes: a systematic review with meta-analysis.

The Journal of international medical research
2025

Treatment of neurological pathology and inflammation in Machado-Joseph disease through in vivo self-assembled siRNA.

Brain : a journal of neurology
2024

A novel mutation in SETX and ATM causes ataxia in consanguineous Pakistani families.

Pakistan journal of medical sciences
2025

Emerging therapies in hereditary ataxias.

Trends in molecular medicine
2024

Oculomotor and Vestibular Deficits in Friedreich Ataxia - Systematic Review and Meta-Analysis of Quantitative Measurements.

Cerebellum (London, England)
2024

Spinocerebellar Ataxias: Phenotypic Spectrum of PolyQ versus Non-Repeat Expansion Forms.

Cerebellum (London, England)
2024

Disease Progression and Multiparametric Imaging Characteristics of Spinocerebellar Ataxia Type 3 With Spastic Paraplegia.

Neurology. Genetics
2024

Elevated Bile Acid 3β,5α,6β-Trihydroxycholanoyl Glycine in a Subset of Adult Ataxias Including Niemann-Pick Type C.

Antioxidants (Basel, Switzerland)
2024

An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease.

Human genomics
2024

Insight into the early pathogenesis and therapeutic strategies of spinocerebellar ataxia type 3/machado-joseph disease from mouse models.

Parkinsonism &amp; related disorders
2024

[Gastrointestinal disorders in hyperkinetic movement disorders and ataxia].

Der Nervenarzt
2024

The genetic basis of early-onset hereditary ataxia in Iran: results of a national registry of a heterogeneous population.

Human genomics
2024

Effect of a Home-Base Core Stability Exercises in Hereditary Ataxia. A Randomized Controlled Trial. A Pilot Randomized Controlled Trial.

Movement disorders clinical practice
2024

Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?

Cells
2024

Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia.

Clinical and translational medicine
2024

Cerebellar Neurostimulation for Boosting Social and Affective Functions: Implications for the Rehabilitation of Hereditary Ataxia Patients.

Cerebellum (London, England)
2024

A systematic review of social cognition in hereditary ataxia patients: Evidence from neuroimaging studies.

Brain research
2023

Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data.

medRxiv : the preprint server for health sciences
2024

Effects of Non-invasive Brain Stimulation on Hereditary Ataxia: a Systematic Review and Meta-analysis.

Cerebellum (London, England)
2023

New Horizons on the Diagnosis of Hereditary Ataxia.

Movement disorders clinical practice
2024

Diagnostic Yield of NGS Tests for Hereditary Ataxia: a Systematic Review.

Cerebellum (London, England)
2023

Generalized myokymia, or neuromyotonia, or both in dogs with or without spinocerebellar ataxia.

Journal of veterinary internal medicine
2024

Cognitive impairment associated with cerebellar volume loss in spinocerebellar ataxia type 3.

Journal of neurology
2023

Repeat expansions in NOP56 are a cause of spinocerebellar ataxia Type 36 in the British population.

Brain communications
2024

Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia.

Journal of neurology
2023

Novel CWF19L1 mutations in patients with spinocerebellar ataxia, autosomal recessive 17.

Journal of human genetics
2023

Detection and discovery of repeat expansions in ataxia enabled by next-generation sequencing: present and future.

Emerging topics in life sciences
2023

Optimising verbal fluency analysis in neurological patients with dysarthria: examples from Parkinson's disease and hereditary ataxia.

Journal of clinical and experimental neuropsychology
2023

Parkinsonism in complex neurogenetic disorders: lessons from hereditary dementias, adult-onset ataxias and spastic paraplegias.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Frequency of GAA-FGF14 Ataxia in a Large Cohort of Brazilian Patients With Unsolved Adult-Onset Cerebellar Ataxia.

Neurology. Genetics
2023

Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data assessments via mobile health app.

BMJ open
2023

Is Social Training Delivered with a Head-Mounted Display Suitable for Patients with Hereditary Ataxia?

Brain sciences
2023

Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): diagnostic contribution of vestibular function tests.

BMJ case reports
2023

Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3.

Molecular medicine (Cambridge, Mass.)
2023

Coexistence of multiple sclerosis and spinocerebellar ataxia type-8.

Multiple sclerosis (Houndmills, Basingstoke, England)
2023

Phenotypic and genetic aspects of hereditary ataxia in dogs.

Journal of veterinary internal medicine
2023

Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain.

Movement disorders clinical practice
2023

Efficacy of high-frequency repetitive transcranial magnetic stimulation in a family with spinocerebellar ataxia type 3: A case report.

Heliyon
2024

Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers.

Cerebellum (London, England)
2024

Standards of NGS Data Sharing and Analysis in Ataxias: Recommendations by the NGS Working Group of the Ataxia Global Initiative.

Cerebellum (London, England)
2024

Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Severity Measures, and Recommended Parameters for Specific Genotypes.

Cerebellum (London, England)
2023

Functional genomics provide key insights to improve the diagnostic yield of hereditary ataxia.

Brain : a journal of neurology
2023

Expanding the spectrum of KIF5A mutations-case report of a large kindred with familial ALS and overlapping syndrome.

Amyotrophic lateral sclerosis &amp; frontotemporal degeneration
2024

Patients' Perspective in Hereditary Ataxia.

Cerebellum (London, England)
2023

Clinical, neuroimaging and genetic findings in children with hereditary ataxia: single center study.

Molecular biology reports
2023

Expansion of the phenotypic and molecular spectrum of CWF19L1-related disorder.

Clinical genetics
2023

AFG3L2 Biallelic Mutation: Clinical Heterogeneity in Two Italian Patients.

Cerebellum (London, England)
2024

Practical recommendations for the clinical evaluation of patients with hereditary ataxia and hereditary spastic paraplegia.

Neurologia
2022

Ataxia with oculomotor apraxia type 1 associated with mutation in the APTX gene: A case study and literature review.

Experimental and therapeutic medicine
2023

Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Spinal cord magnetic resonance imaging and spectroscopy detect early-stage alterations and disease progression in Friedreich ataxia.

Brain communications
2022

Characterization of the central motor conduction time in a large cohort of spinocerebellar ataxia type 3 patients.

Parkinsonism &amp; related disorders
2023

Parallel in-depth analysis of repeat expansions in ataxia patients by long-read sequencing.

Brain : a journal of neurology
2022

A Rare Phenotype of Inherited Cerebellar Ataxia.

Cureus
2023

Acute frataxin knockdown in induced pluripotent stem cell-derived cardiomyocytes activates a type I interferon response.

Disease models &amp; mechanisms
2022

Ataxia due to vitamin E deficiency: A case report and updated review.

Clinical case reports
2023

Clinical Features and Neuroimaging Findings of Neuropil Antibody-Positive Idiopathic Sporadic Ataxia of Unknown Etiology.

Cerebellum (London, England)
2022

Comorbidities in Friedreich ataxia: incidence and manifestations from early to advanced disease stages.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Perspectives on current models of Friedreich's ataxia.

Frontiers in cell and developmental biology
2022

Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review.

Brain sciences
2022

Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

A PNPLA8 frameshift variant in Australian shepherd dogs with hereditary ataxia.

Animal genetics
2023

Nutritional status and eating habits of patients with hereditary ataxias: a case-control study.

Nutritional neuroscience
2023

An Exploratory Survey on the Care for Ataxic Patients in the American Continents and the Caribbean.

Cerebellum (London, England)
2023

A homozygous variant in CHMP3 is associated with complex hereditary spastic paraplegia.

Journal of medical genetics
2022

Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.

BMC neurology
2022

Effects of Repetitive Transcranial Magnetic Stimulation on Cerebellar Metabolism in Patients With Spinocerebellar Ataxia Type 3.

Frontiers in aging neuroscience
2022

Neuropsychological Profile of Hereditary Ataxias: Study of 38 Patients.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
2022

Spinocerebellar ataxia in a cohort of patients from Rio de Janeiro.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Differential diagnosis between Parkinson's disease and atypical parkinsonism based on gait and postural instability: Artificial intelligence using an enhanced weight voting ensemble model.

Parkinsonism &amp; related disorders
2022

Lipid Dyshomeostasis and Inherited Cerebellar Ataxia.

Molecular neurobiology
2022

The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patients.

Journal of neurology
2022

Effectiveness of functional trunk training on trunk control and upper limb functions in patients with autosomal recessive hereditary ataxia.

NeuroRehabilitation
2023

Spinocerebellar Ataxia Type 5 (SCA5) Mimicking Cerebral Palsy: a Very Early Onset Autosomal Dominant Hereditary Ataxia.

Cerebellum (London, England)
2023

Effects of therapeutic exercise on disease severity, balance, and functional Independence among individuals with cerebellar ataxia: A systematic review with meta-analysis.

Physiotherapy theory and practice
2022

A Diagnostic Approach to Spastic ataxia Syndromes.

Cerebellum (London, England)
2022

Spinal cord-predominant neuropathology in an adult-onset case of POLR3A-related spastic ataxia.

Neuropathology : official journal of the Japanese Society of Neuropathology
2021

Left atrial appendage thrombosis in a patient with Friedreich Ataxia-related cardiomyopathy, left ventricular systolic dysfunction, and atrial fibrillation.

SAGE open medical case reports
2021

A Novel Calpain Inhibitor Compound Has Protective Effects on a Zebrafish Model of Spinocerebellar Ataxia Type 3.

Cells
2021

Molecular epidemiology of hereditary ataxia in Finland.

BMC neurology
2022

Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review.

Journal of neurology
2021

NGS in Hereditary Ataxia: When Rare Becomes Frequent.

International journal of molecular sciences
2021

Efficient Neuroprotective Rescue of Sacsin-Related Disease Phenotypes in Zebrafish.

International journal of molecular sciences
2021

Rare occurrence of severe blindness and deafness in Friedreich ataxia: a case report.

Cerebellum &amp; ataxias
2021

Milestones in genetics of cerebellar ataxias.

Neurogenetics
2021

Epilepsy and episodic ataxia type 2: family study and review of the literature.

Journal of neurology
2021

Between responsibility and desire: Accounts of reproductive decisions from those at risk for or affected by late-onset neurological diseases.

Journal of genetic counseling
2021

Congenital ataxia due to novel variant in ATP8A2.

Clinical genetics
2021

Genetic ataxias: update on classification and diagnostic approaches.

Current neurology and neuroscience reports
2021

Neuromodulation of the cerebellum rescues movement in a mouse model of ataxia.

Nature communications
2021

Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review.

Chinese medicine
2021

Genetic and Epidemiological Study of Adult Ataxia and Spastic Paraplegia in Eastern Quebec.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2020

A novel case of congenital spinocerebellar ataxia 5: further support for a specific phenotype associated with the p.(Arg480Trp) variant in SPTBN2.

BMJ case reports
2021

Longitudinal Study of Cognitive Functioning in Friedreich's Ataxia.

Journal of the International Neuropsychological Society : JINS
2020

Clinical Features and Molecular Genetics of Autosomal Recessive Ataxia in the Turkish Population.

Journal of pediatric neurosciences
2020

DINAX- a comprehensive database of inherited ataxias.

Computers in biology and medicine
2020

Homozygosity mapping and next generation sequencing for the genetic diagnosis of hereditary ataxia and spastic paraplegia in consanguineous families.

Parkinsonism &amp; related disorders
2020

Altered Secretome and ROS Production in Olfactory Mucosa Stem Cells Derived from Friedreich's Ataxia Patients.

International journal of molecular sciences
2020

Novel homozygous variant of carbonic anhydrase 8 gene expanding the phenotype of cerebellar ataxia, mental retardation, and disequilibrium syndrome subtype 3.

American journal of medical genetics. Part A
2020

Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) in a Thai Patient: The Classic Clinical Manifestations, Funduscopic Feature, and Brain Imaging Findings with a Novel Mutation in the SACS Gene.

Tremor and other hyperkinetic movements (New York, N.Y.)
2019

Identification of Two Novel Mutations in the ATM Gene from Patients with Ataxia-Telangiectasia by Whole Exome Sequencing.

Current genomics
2020

Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.

European journal of pharmacology
2020

Mesenchymal stem cell-derived exosomes improve motor function and attenuate neuropathology in a mouse model of Machado-Joseph disease.

Stem cell research &amp; therapy
2020

Hereditary Ataxia: A Focus on Heme Metabolism and Fe-S Cluster Biogenesis.

International journal of molecular sciences
2020

[CANVAS: case report on a novel repeat expansion disorder with late-onset ataxia].

Der Nervenarzt
2020

Reconstructing the History of Machado-Joseph Disease.

European neurology
2020

Bi-allelic mutations in HARS1 severely impair histidyl-tRNA synthetase expression and enzymatic activity causing a novel multisystem ataxic syndrome.

Human mutation
2020

[Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2020

Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia.

Proceedings of the National Academy of Sciences of the United States of America
2020

Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Cerebellum (London, England)
2020

Characterisation of canine KCNIP4: A novel gene for cerebellar ataxia identified by whole-genome sequencing two affected Norwegian Buhund dogs.

PLoS genetics
2019

Swimming in Deep Water: Zebrafish Modeling of Complicated Forms of Hereditary Spastic Paraplegia and Spastic Ataxia.

Frontiers in neuroscience
2020

Genetic Analysis of Hereditary Ataxias in Peru Identifies SCA10 Families with Incomplete Penetrance.

Cerebellum (London, England)
2020

Age of onset determines intrinsic functional brain architecture in Friedreich ataxia.

Annals of clinical and translational neurology
2020

Childhood-onset autosomal recessive ataxias: a cross-sectional study from Turkey.

Neurogenetics
2019

A Preventable Ataxia: Cerebrotendinous Xanthomatosis.

Annals of Indian Academy of Neurology
2020

Cerebellar ataxia with normal intellect associated with a homozygous truncating variant in CA8.

Clinical genetics
2020

POLR3A-related spastic ataxia: new mutations and a look into the phenotype.

Journal of neurology
2019

Ataxia in Patients With Bi-Allelic NFASC Mutations and Absence of Full-Length NF186.

Frontiers in genetics
2019

Changes detected in swallowing function in Friedreich ataxia over 12 months.

Neuromuscular disorders : NMD
2019

Backbone resonance assignments and secondary structure of the apo-Drosophila melanogaster frataxin homolog (Dfh).

Biomolecular NMR assignments
2019

Whole exome and targeted gene sequencing to detect pathogenic recessive variants in early onset cerebellar ataxia.

Clinical genetics
2019

Dysarthria Profiles in Adults With Hereditary Ataxia.

American journal of speech-language pathology
2019

Identification of a novel mutation in the CACNA1C gene in a Chinese family with autosomal dominant cerebellar ataxia.

BMC neurology
2019

Phenotypic and Genotypic Analysis of Hereditary Ataxia Patients in Sakarya City, Turkey.

Noro psikiyatri arsivi
2019

Hereditary Ataxia with a Novel Mutation in the Senataxin Gene: A Case Report.

Iranian journal of medical sciences
2019

Truncating SLC12A6 variants cause different clinical phenotypes in humans and dogs.

European journal of human genetics : EJHG
2019

Deafness and Vestibulopathy in Cerebellar Diseases: a Practical Approach.

Cerebellum (London, England)
2019

Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms.

Stereotactic and functional neurosurgery
2019

Persistent motor dysfunction despite homeostatic rescue of cerebellar morphogenesis in the Car8 waddles mutant mouse.

Neural development
2019

Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias.

CNS &amp; neurological disorders drug targets
2019

Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy.

Parkinsonism &amp; related disorders
2019

Biallelic POLR3A variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis.

Brain : a journal of neurology
2019

Guidelines on the diagnosis and management of the progressive ataxias.

Orphanet journal of rare diseases
2019

A network biology approach to unraveling inherited axonopathies.

Scientific reports
2019

Acetazolamide-Responsive Episodic Ataxia Linked to Novel Splice Site Variant in FGF14 Gene.

Cerebellum (London, England)
2019

Past and Present of Eye Movement Abnormalities in Ataxia-Telangiectasia.

Cerebellum (London, England)
2019

A case series of hereditary cerebellar ataxias in a highly consanguineous population from Northeast Brazil.

Parkinsonism &amp; related disorders
2018

Hereditary ataxia in four related Norwegian Buhunds.

Journal of the American Veterinary Medical Association
2019

Prevalence and phenotype of the c.1529C>T SPG7 variant in adult-onset cerebellar ataxia in Italy.

European journal of neurology
2018

Laboratory investigations.

Handbook of clinical neurology
2018

Intrathecal Baclofen Therapy for Painful Muscle Spasms in a Patient with Friedreich's Ataxia.

Stereotactic and functional neurosurgery
2018

Serum antigliadin antibodies in cerebellar ataxias: a systematic review and meta-analysis.

Journal of neurology, neurosurgery, and psychiatry
2018

Evaluation of Various Movement Disorders in Patients of Genetically Proven Spinocerebellar Ataxia: A Study from a Tertiary Care Center in Northern India.

Annals of Indian Academy of Neurology
2018

Pitfalls in molecular diagnosis of Friedreich ataxia.

European journal of medical genetics
2018

Molecular genetic testing for hereditary ataxia: What every neurologist should know.

Neurology. Clinical practice
2018

Ode to the humble Southern blot in the era of exomes.

Neurology. Clinical practice
2018

Small RNA-seq analysis of circulating miRNAs to identify phenotypic variability in Friedreich's ataxia patients.

Scientific data
2018

Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.

PloS one
2018

The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis.

Drug delivery
2017

Mortality Statistics and their Contribution to Improving the Knowledge of Rare Diseases Epidemiology: The Example of Hereditary Ataxia in Europe.

Advances in experimental medicine and biology
2017

Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging.

World journal of radiology
2017

Ataxia in Childhood: Epidemiological, Clinical and Neuroradiologic Features, and the Risk of Recurrence.

Iranian journal of child neurology
2017

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) - A Polish family with novel SACS mutations.

Neurologia i neurochirurgia polska
2017

A homozygous missense variant in HSD17B4 identified in a consanguineous Chinese Han family with type II Perrault syndrome.

BMC medical genetics
Ver todos os 199 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ataxia hereditária.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Ataxia hereditária

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review.
    International journal of molecular sciences· 2026· PMID 41596528mais citado
  2. Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxia.
    Molecular therapy : the journal of the American Society of Gene Therapy· 2026· PMID 41137390mais citado
  3. Repeat-associated ataxias in a German patient cohort analysed by targeted parallel long-read sequencing.
    Brain : a journal of neurology· 2026· PMID 40898875mais citado
  4. Clinical and genetic diagnostic challenges in presumed hereditary ataxia.
    Journal of neurology· 2026· PMID 41870659mais citado
  5. Exploring the Potential of Scales to Assess Different Types of Ataxia: Meta-review.
    Cerebellum (London, England)· 2026· PMID 41824138mais citado
  6. CGG Repeat Expansion in GIPC1 is Associated with Childhood-Onset Hereditary Ataxia.
    Mov Disord· 2026· PMID 41975469recente
  7. Longitudinal analysis shows GAA1 length and baseline clinical status as robust predictors of progression in Friedreich ataxia.
    J Neurol· 2026· PMID 41954755recente
  8. Home-Based Telerehabilitation for Core Stability in Hereditary Ataxia: Feasibility and Preliminary Effects of a Pilot RCT.
    NeuroRehabilitation· 2026· PMID 41949495recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:183518(Orphanet)
  2. MONDO:0100309(MONDO)
  3. GARD:20286(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q3731293(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Ataxia hereditária
Compêndio · Raras BR

Ataxia hereditária

ORPHA:183518 · MONDO:0100309
Prevalência
Unknown
CID-10
G11 · Ataxia hereditária
Ensaios
3 ativos
Prevalência
0.0 (Worldwide)
UMLS
C0004138
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades